"PubSID","Name"
"84942194252","Antineoplastic Combined Chemotherapy Protocols"
"84942194252","Humans"
"84942194252","Molecular Targeted Therapy"
"84942194252","Neoplasm Metastasis"
"84942194252","Neoplasm Recurrence, Local"
"84942194252","Receptor, ErbB-2"
"84942194252","Stomach Neoplasms"
"84953881828","Angiogenesis Inhibitors"
"84953881828","Antineoplastic Agents"
"84953881828","Carcinoma, Hepatocellular"
"84953881828","Drug Design"
"84953881828","Humans"
"84953881828","Liver Neoplasms"
"84953881828","Neovascularization, Pathologic"
"84953881828","Niacinamide"
"84953881828","Phenylurea Compounds"
"84935027410","Angiogenesis Inhibitors"
"84935027410","Animals"
"84935027410","Antibodies, Monoclonal"
"84935027410","Humans"
"84935027410","Neovascularization, Pathologic"
"84935027410","Receptors, Vascular Endothelial Growth Factor"
"84935027410","Urinary Bladder Neoplasms"
"84935027410","Vascular Endothelial Growth Factor A"
"84946235122","Antibodies, Monoclonal"
"84946235122","Antineoplastic Agents"
"84946235122","Hematologic Diseases"
"84946235122","Humans"
"84946235122","Incidence"
"84946235122","Neoplasms"
"84946235122","Odds Ratio"
"84946235122","Risk"
"84946235122","Severity of Illness Index"
"84938840932","Angiogenesis Inhibitors"
"84938840932","Antibodies, Monoclonal"
"84938840932","Breast Neoplasms"
"84938840932","Clinical Trials as Topic"
"84938840932","Female"
"84938840932","Gastrointestinal Neoplasms"
"84938840932","Humans"
"84938840932","Lung Neoplasms"
"84938840932","Neovascularization, Pathologic"
"84938840932","Vascular Endothelial Growth Factor Receptor-2"
"84937517268","Angiogenesis Inhibitors"
"84937517268","Antibodies, Monoclonal"
"84937517268","Carcinoma"
"84937517268","Esophageal Neoplasms"
"84937517268","Humans"
"84937517268","Membrane Proteins"
"84937517268","Neovascularization, Pathologic"
"84937517268","Proto-Oncogene Proteins c-met"
"84937517268","Stomach Neoplasms"
"84937517268","Vascular Endothelial Growth Factor Receptor-2"
"84922665326","Angiogenesis Inhibitors"
"84922665326","Antibodies, Monoclonal"
"84922665326","Antibodies, Monoclonal, Humanized"
"84922665326","Antineoplastic Agents"
"84922665326","Carcinoma, Non-Small-Cell Lung"
"84922665326","Disease Progression"
"84922665326","Humans"
"84922665326","Indoles"
"84922665326","Lung Neoplasms"
"84922665326","Molecular Targeted Therapy"
"84922665326","Neovascularization, Pathologic"
"84922665326","Taxoids"
"84922665326","Vascular Endothelial Growth Factor A"
"84928295481","Antibodies, Monoclonal"
"84928295481","Antibodies, Monoclonal, Humanized"
"84928295481","Antineoplastic Agents"
"84928295481","Clinical Trials as Topic"
"84928295481","Hepatocyte Growth Factor"
"84928295481","Humans"
"84928295481","Molecular Targeted Therapy"
"84928295481","Proto-Oncogene Proteins c-met"
"84928295481","Receptor, Epidermal Growth Factor"
"84928295481","Receptor, ErbB-2"
"84928295481","Stomach Neoplasms"
"84928295481","TOR Serine-Threonine Kinases"
"84928295481","Vascular Endothelial Growth Factor Receptor-2"
"84937032951","Adenocarcinoma"
"84937032951","Angiogenesis Inhibitors"
"84937032951","Animals"
"84937032951","Antineoplastic Agents"
"84937032951","Carcinoma, Non-Small-Cell Lung"
"84937032951","Drug Approval"
"84937032951","Drug Evaluation, Preclinical"
"84937032951","Humans"
"84937032951","Indoles"
"84937032951","Lung Neoplasms"
"84937032951","Neovascularization, Pathologic"
"85003052752","Adenocarcinoma"
"85003052752","Animals"
"85003052752","Carcinoma, Squamous Cell"
"85003052752","Disease Management"
"85003052752","Humans"
"85003052752","Lung Neoplasms"
"85003052752","Small Cell Lung Carcinoma"
"84929190537","Antineoplastic Agents"
"84929190537","Hepatocyte Growth Factor"
"84929190537","Humans"
"84929190537","Prognosis"
"84929190537","Proto-Oncogene Proteins c-met"
"84929190537","Receptor, ErbB-2"
"84929190537","Signal Transduction"
"84929190537","Stomach Neoplasms"
"84931457947","Angiogenesis Inhibitors"
"84931457947","Antibodies, Monoclonal"
"84931457947","Antibodies, Monoclonal, Humanized"
"84931457947","Antineoplastic Agents"
"84931457947","Carcinoma, Non-Small-Cell Lung"
"84931457947","Disease-Free Survival"
"84931457947","Hemorrhage"
"84931457947","Humans"
"84931457947","Indoles"
"84931457947","Lung Neoplasms"
"84931457947","Niacinamide"
"84931457947","Odds Ratio"
"84931457947","Phenylurea Compounds"
"84931457947","Piperidines"
"84931457947","Pyrimidines"
"84931457947","Pyrroles"
"84931457947","Quinazolines"
"84931457947","Randomized Controlled Trials as Topic"
"84931457947","Receptors, Vascular Endothelial Growth Factor"
"84931457947","Signal Transduction"
"84931457947","Sulfonamides"
"84931457947","Thrombocytopenia"
"84931457947","Treatment Outcome"
"84931457947","Vascular Endothelial Growth Factor A"
"84921345093","Animals"
"84921345093","Antibodies, Monoclonal"
"84921345093","Antineoplastic Agents"
"84921345093","Clinical Trials, Phase III as Topic"
"84921345093","Humans"
"84921345093","United States"
"84923281576","Antibodies, Monoclonal"
"84923281576","Antineoplastic Agents"
"84923281576","Drug Design"
"84923281576","Esophageal Neoplasms"
"84923281576","Humans"
"84923281576","Molecular Targeted Therapy"
"84923281576","Prognosis"
"84923281576","Stomach Neoplasms"
"84923281576","Survival Rate"
"84916918721","Angiogenesis Inhibitors"
"84916918721","Antineoplastic Agents"
"84916918721","Biomarkers"
"84916918721","Breast Neoplasms"
"84916918721","Clinical Trials as Topic"
"84916918721","Female"
"84916918721","Humans"
"84916918721","Molecular Targeted Therapy"
"84916918721","Neoplasm Staging"
"84916918721","Neovascularization, Pathologic"
"84916918721","Treatment Outcome"
"84916918721","Vascular Endothelial Growth Factor A"
"84928531309","Antineoplastic Agents"
"84928531309","Carcinoma, Hepatocellular"
"84928531309","Humans"
"84928531309","Liver Neoplasms"
"84928531309","Molecular Targeted Therapy"
"84928531309","Neoplasm Staging"
"84928531309","Patient Selection"
"84928531309","Predictive Value of Tests"
"84928531309","Signal Transduction"
"84928531309","Treatment Outcome"
"84921362441","Antibodies, Anti-Idiotypic"
"84921362441","Antibodies, Monoclonal"
"84921362441","Antineoplastic Agents"
"84921362441","Humans"
"84921362441","Receptors, Vascular Endothelial Growth Factor"
"84921362441","Signal Transduction"
"84921362441","Stomach Neoplasms"
"84921362441","Survival Rate"
"84921362441","Treatment Outcome"
"84921362441","Tumor Markers, Biological"
"84921362441","Vascular Endothelial Growth Factor A"
"84918573384","Angiogenesis Inhibitors"
"84918573384","Antibodies, Monoclonal"
"84918573384","Antineoplastic Agents"
"84918573384","Clinical Trials as Topic"
"84918573384","Humans"
"84918573384","Molecular Targeted Therapy"
"84918573384","Neovascularization, Pathologic"
"84918573384","Stomach Neoplasms"
"84918573384","Treatment Outcome"
"84918573384","Vascular Endothelial Growth Factor A"
"84918573384","Vascular Endothelial Growth Factor Receptor-2"
"84907486352","Antibodies, Monoclonal"
"84907486352","Antineoplastic Agents"
"84907486352","Databases, Factual"
"84907486352","Humans"
"84907486352","Neoplasm Staging"
"84907486352","Stomach Neoplasms"
"84907486352","Survival Rate"
"84907486352","Taxoids"
"84927649692","Antineoplastic Agents"
"84927649692","Chemotherapy, Adjuvant"
"84927649692","Clinical Protocols"
"84927649692","Gastrectomy"
"84927649692","Humans"
"84927649692","Neoadjuvant Therapy"
"84927649692","Neoplasm Staging"
"84927649692","Palliative Care"
"84927649692","Radiotherapy, Adjuvant"
"84927649692","Stomach Neoplasms"
"84927649692","United States"
"84928044744","Adenocarcinoma"
"84928044744","Antibodies, Monoclonal"
"84928044744","Antineoplastic Agents"
"84928044744","Bevacizumab"
"84928044744","Biomarkers, Tumor"
"84928044744","Humans"
"84928044744","Prognosis"
"84928044744","Proto-Oncogene Proteins c-met"
"84928044744","Receptor, Epidermal Growth Factor"
"84928044744","Receptor, ErbB-2"
"84928044744","Stomach Neoplasms"
"84928044744","TOR Serine-Threonine Kinases"
"84928044744","Vascular Endothelial Growth Factor A"
"84928044744","Vascular Endothelial Growth Factors"
"84909989459","Angiogenesis Inhibitors"
"84909989459","Animals"
"84909989459","Antineoplastic Agents"
"84909989459","Biomarkers, Tumor"
"84909989459","Drug Design"
"84909989459","Humans"
"84909989459","Molecular Diagnostic Techniques"
"84909989459","Molecular Targeted Therapy"
"84909989459","Patient Selection"
"84909989459","Predictive Value of Tests"
"84909989459","Protein Kinase Inhibitors"
"84909989459","Signal Transduction"
"84909989459","Stomach Neoplasms"
"84909989459","Treatment Outcome"
"84923279264","Angiogenesis Inhibitors"
"84923279264","Animals"
"84923279264","Antibodies, Monoclonal, Humanized"
"84923279264","Clinical Trials, Phase III as Topic"
"84923279264","Colorectal Neoplasms"
"84923279264","Drug Screening Assays, Antitumor"
"84923279264","Humans"
"84923279264","Phenylurea Compounds"
"84923279264","Pyridines"
"84923279264","Receptors, Vascular Endothelial Growth Factor"
"84923279264","Recombinant Fusion Proteins"
"84923279264","Tumor Microenvironment"
"84910003792","Antineoplastic Combined Chemotherapy Protocols"
"84910003792","Chemoradiotherapy, Adjuvant"
"84910003792","Chemotherapy, Adjuvant"
"84910003792","Humans"
"84910003792","Molecular Targeted Therapy"
"84910003792","Neoadjuvant Therapy"
"84910003792","Risk Factors"
"84910003792","Stomach Neoplasms"
"84910003792","Survival Analysis"
"84910003792","Treatment Outcome"
"84921728501","Antineoplastic Agents"
"84921728501","Carcinoma, Hepatocellular"
"84921728501","Humans"
"84921728501","Liver Neoplasms"
"84921728501","Niacinamide"
"84921728501","Patient Selection"
"84921728501","Phenylurea Compounds"
"84921728501","Treatment Outcome"
"84906777617","Anti-Bacterial Agents"
"84906777617","Helicobacter Infections"
"84906777617","Helicobacter pylori"
"84906777617","Humans"
"84906777617","Stomach Neoplasms"
"84925610511","Angiogenesis Inhibitors"
"84925610511","Animals"
"84925610511","Antibodies, Monoclonal"
"84925610511","Antibodies, Monoclonal, Humanized"
"84925610511","Antineoplastic Agents"
"84925610511","Clinical Trials as Topic"
"84925610511","Humans"
"84925610511","Molecular Targeted Therapy"
"84925610511","Neovascularization, Pathologic"
"84925610511","Prognosis"
"84925610511","Receptors, Vascular Endothelial Growth Factor"
"84925610511","Signal Transduction"
"84925610511","Stomach Neoplasms"
"84925610511","Vascular Endothelial Growth Factor A"
"84916199585","Animals"
"84916199585","Antibodies, Monoclonal"
"84916199585","Antineoplastic Agents"
"84916199585","Humans"
"84916199585","Molecular Targeted Therapy"
"84916199585","Stomach Neoplasms"
"84916199585","Vascular Endothelial Growth Factor A"
"84902313634","Animals"
"84902313634","Antineoplastic Agents"
"84902313634","Drug Resistance, Neoplasm"
"84902313634","Germ-Line Mutation"
"84902313634","Hepatocyte Growth Factor"
"84902313634","Humans"
"84902313634","Molecular Targeted Therapy"
"84902313634","Proto-Oncogene Proteins c-met"
"84902313634","Receptor, Epidermal Growth Factor"
"84902313634","Receptor, ErbB-2"
"84902313634","Stomach Neoplasms"
"84902313634","TOR Serine-Threonine Kinases"
"84905025438","Antineoplastic Combined Chemotherapy Protocols"
"84905025438","Clinical Trials, Phase II as Topic"
"84905025438","Clinical Trials, Phase III as Topic"
"84905025438","Humans"
"84905025438","Molecular Targeted Therapy"
"84905025438","Stomach Neoplasms"
"84905025438","Survival Rate"
"84904044814","Adenocarcinoma"
"84904044814","Antibodies, Monoclonal"
"84904044814","Antineoplastic Agents"
"84904044814","Antineoplastic Combined Chemotherapy Protocols"
"84904044814","Disease Progression"
"84904044814","Drug Approval"
"84904044814","Drug Screening Assays, Antitumor"
"84904044814","Esophageal Neoplasms"
"84904044814","Esophagogastric Junction"
"84904044814","Humans"
"84904044814","Stomach Neoplasms"
"84904044814","Vascular Endothelial Growth Factor Receptor-2"
"84905858700","Angiogenesis Inhibitors"
"84905858700","Animals"
"84905858700","Antibodies, Monoclonal"
"84905858700","Esophageal Neoplasms"
"84905858700","Humans"
"84905858700","Neovascularization, Pathologic"
"84905858700","Protein Kinase Inhibitors"
"84905858700","Protein-Tyrosine Kinases"
"84905858700","Receptors, Vascular Endothelial Growth Factor"
"84905858700","Stomach Neoplasms"
"84905858700","Vascular Endothelial Growth Factor A"
"84901586010","Antineoplastic Agents"
"84901586010","Carcinoma, Hepatocellular"
"84901586010","Hepatectomy"
"84901586010","Humans"
"84901586010","Liver Neoplasms"
"84901586010","Liver Transplantation"
"84901586010","Niacinamide"
"84901586010","Phenylurea Compounds"
"84905827126","Angiogenesis Inhibitors"
"84905827126","Antibodies, Monoclonal"
"84905827126","Antibodies, Monoclonal, Humanized"
"84905827126","Breast Neoplasms"
"84905827126","Clinical Trials, Phase III as Topic"
"84905827126","Disease-Free Survival"
"84905827126","Female"
"84905827126","Humans"
"84905827126","Treatment Outcome"
"84905827126","Vascular Endothelial Growth Factor Receptor-2"
"84903175348","Animals"
"84903175348","Antineoplastic Agents"
"84903175348","Drug Design"
"84903175348","Humans"
"84903175348","Molecular Targeted Therapy"
"84903175348","Signal Transduction"
"84903175348","Stomach Neoplasms"
"84903175348","Treatment Outcome"
"84903175348","Tumor Markers, Biological"
"0035800507","Cancer therapy"
"0005984244","TRANSPLANTATION"
"0345615911","KIDNEY/transplantation"
"0345615911","MERCAPTOPURINE/related compounds"
"77049284622","KIDNEYS/transplantation"
"77049284622","TWINS"
"73649153279","ACTINOMYCIN"
"73649153279","AZASERINE"
"73649153279","IMIDAZOLES"
"73649153279","KIDNEY TRANSPLANTATION"
"73649153279","MERCAPTOPURINE"
"73649153279","PREDNISONE"
"0001082014","BONE MARROW/transplantation"
"0001082014","LEUKEMIA/radiotherapy"
"0001082014","RADIATION INJURY/therapy"
"0001082014","RADIATION PROTECTION"
"0035902180","Multicellular communication"
"0035800763","Phosphorylation"
"0035800763","Plasma membranes"
"0035368548","Insulin resistance"
"0035914388","Isoforms"
"0035844257","Phosphorylation"
"0035902115","Cell cycle"
"0035854677","Apoptosis"
"0035854677","Phosphorylation"
"0035850916","Transformation"
"0035813230","Signal transduction"
"0035920145","Apoptosis"
"0035920145","Serine"
"0037059834","Microarray"
"0035413616","Cyclin dependent kinases"
"0035470983","Light-emitting probes"
"0035816685","Embryonic cultures"
"0035413618","Nuclear hormone receptors"
"0035413606","Neurotransmitter biosynthesis"
"0034962383","Pseudo atomic receptor model (PARM)"
"0035385131","Molecular field analysis (MFA)"
"0035812694","Genomics"
"0035477020","Cell adhesion"
"10744220576","Apoptosis"
"10744220576","Cell lines"
"0035968166","Oligomerization"
"0035951860","Hematopoiesis"
"0035951860","Hypermotility"
"0035072249","Microarrays"
"0035913337","Drug resistance"
"0020972981","Abelson murine leukemia virus"
"0020972981","Cell Transformation, Neoplastic"
"0020972981","Chromosome Mapping"
"0020972981","Chromosomes, Human, 21-22 and Y"
"0020972981","Chromosomes, Human, 6-12 and X"
"0020972981","Humans"
"0020972981","Hybrid Cells"
"0020972981","Leukemia, Myeloid"
"0020972981","Male"
"0020972981","Nucleic Acid Hybridization"
"0020972981","Oncogenes"
"0020972981","Translocation, Genetic"
"0002885724","BUSULFAN/therapy"
"0002885724","LEUKEMIA, MYELOCYTIC/therapy"
"0002943076","ADENINE"
"0002943076","CHROMATOGRAPHY"
"0002943076","EXPERIMENTAL LAB STUDY"
"0002943076","NUCLEOSIDES"
"0002943076","ULTRAVIOLET RAYS"
"5044225888","Mutations"
"5044225888","Translocations"
"5044225888","Transmembranes"
"0035943311","Convergent syntheses"
"0035941203","Protein isoforms"
"0037182861","Haematopoiesis"
"0037182861","Mice"
"30744477950","Angiogenesis"
"30744477950","Pathological conditions"
"11844254414","Antiangiogenic therapies"
"11844254414","Tumor vasculature"
"11844254414","Vascular normalization"
"3142676436","Bone marrow"
"3142676436","Chronic myeloid leukemia (CML)"
"3142676436","Mutations"
"3142676436","Progenitors"
"4644305806","Phosphorylation"
"4644305806","Signalling"
"4644305806","Substrate domain (SD)"
"0141599428","Phosphorylation"
"20444427212","Epidermal growth factor receptors (EGFR)"
"20444427212","Kinase inhibitors"
"20444427212","Virtual screening (VS)"
"20444427212","Water molecules"
"18244409687","Local lymph nodes"
"30744477450","Lymphangionesgensis"
"30744477450","Lymphatic vessels"
"19644394554","Growth factor"
"19644394554","Intracellular production"
"19644394554","Platelet-derived growth factor (PDGF)"
"19644394554","Vascular remodeling"
"0242670019","Gastrointestinal stromal tumors (GIST)"
"33748751207","Hyaluronan"
"33748751207","Inhibitory effects"
"33748751207","Platelet derived growth factor (PDGF)"
"33748751207","Receptor activation"
"2342624080","Growth inhibition"
"2342624080","Lung cancer"
"2342624080","Mutations"
"2342624080","Tyrosine kinase"
"0035805546","Phosphorylation"
"18444368709","Structural basis"
"33645340325","Angiogenesis"
"33645340325","Lung cancer cells"
"33645340325","Vascular targeting"
"33645340325","ZD6126"
"0242581718","Cancer cells"
"7444259131","Antitumor efficacy"
"7444259131","Human renal cell carcinoma"
"7444259131","Tumor growth"
"7444259131","Vessel formation"
"30744449235","Antiangiogenic agents"
"30744449235","Macular degeneration"
"30744449235","Morphogenesis"
"28644432204","Metastasis"
"28644432204","Tumour cells"
"0037423321","Homeostasis"
"0037154738","Antiangiogenic therapy"
"4143066760","Apoptosis"
"4143066760","Lung cancer"
"18444374405","Mutations"
"34247327408","ADENOCARCINOMA"
"34247327408","BONE NEOPLASMS"
"34247327408","CARCINOGENS"
"34247327408","DIETHYLSTILBESTROL"
"34247327408","EXPERIMENTAL LAB STUDY"
"34247327408","HAMSTERS"
"34247327408","KIDNEY NEOPLASMS"
"34247327408","LUNG NEOPLASMS"
"34247327408","NEOPLASM METASTASIS"
"34247327408","NEOPLASM REGRESSION, SPONTANEOUS"
"34247327408","NEOPLASM THERAPY"
"34247327408","NEOPLASMS, EXPERIMENTAL"
"34247327408","PATHOLOGY"
"34247327408","RADIOGRAPHY"
"34247327408","TESTOSTERONE"
"19744365702","Clinical kinase inhibitors"
"19744365702","Epidermal growth factor receptor (EGFR)"
"19744365702","Molecule-kinase interaction map"
"24744465206","Farnesyl transferase inhibitor (FTI)"
"24744465206","Geranylgeranyl transferase-1"
"24744465206","MCF-7 breast cancer cells"
"24744465206","Rapamycin treatment"
"0035920244","Endothelium"
"10744221013","Ligand binding"
"10744221013","Tumor growth inhibition"
"2342557044","Cell growth"
"2342557044","Epidermal growth factor receptor (EGFR)"
"84918815964","Adolescent"
"84918815964","Adult"
"84918815964","Aged"
"84918815964","Child"
"84918815964","Child, Preschool"
"84918815964","Female"
"84918815964","Follow-Up Studies"
"84918815964","Global Health"
"84918815964","Humans"
"84918815964","Incidence"
"84918815964","Infant"
"84918815964","Infant, Newborn"
"84918815964","Male"
"84918815964","Middle Aged"
"84918815964","Mortality"
"84918815964","Neoplasms"
"84918815964","Prognosis"
"84918815964","Registries"
"84918815964","Risk Factors"
"84918815964","Survival Rate"
"84918815964","Young Adult"
"84900437949","Cohort Studies"
"84900437949","Female"
"84900437949","GTP Phosphohydrolases"
"84900437949","Humans"
"84900437949","Male"
"84900437949","Membrane Proteins"
"84900437949","Middle Aged"
"84900437949","Mutation"
"84900437949","Neoplasm Staging"
"84900437949","Phosphatidylinositol 3-Kinases"
"84900437949","Prognosis"
"84900437949","Proto-Oncogene Proteins"
"84900437949","Proto-Oncogene Proteins B-raf"
"84900437949","Stomach Neoplasms"
"84900437949","ras Proteins"
"77956262693","Adenocarcinoma"
"77956262693","Aged"
"77956262693","Antibodies, Monoclonal"
"77956262693","Antibodies, Monoclonal, Humanized"
"77956262693","Antineoplastic Agents"
"77956262693","Antineoplastic Combined Chemotherapy Protocols"
"77956262693","Cisplatin"
"77956262693","Deoxycytidine"
"77956262693","Drug Therapy, Combination"
"77956262693","Esophagogastric Junction"
"77956262693","Female"
"77956262693","Fluorouracil"
"77956262693","Humans"
"77956262693","Male"
"77956262693","Middle Aged"
"77956262693","Receptor, ErbB-2"
"77956262693","Stomach Neoplasms"
"77956262693","Survival Analysis"
"77956262693","Treatment Outcome"
"84886788915","5-Fluorouracil"
"84886788915","Cisplatin"
"84886788915","FLAGS"
"84886788915","Gastric"
"84886788915","Phase 3"
"84886788915","S-1"
"84905028489","Adenocarcinoma"
"84905028489","Adult"
"84905028489","Aged"
"84905028489","Antibodies, Monoclonal"
"84905028489","Antineoplastic Combined Chemotherapy Protocols"
"84905028489","Cisplatin"
"84905028489","Confidence Intervals"
"84905028489","Deoxycytidine"
"84905028489","Disease-Free Survival"
"84905028489","Dose-Response Relationship, Drug"
"84905028489","Double-Blind Method"
"84905028489","Drug Administration Schedule"
"84905028489","Epirubicin"
"84905028489","Esophagogastric Junction"
"84905028489","Female"
"84905028489","Fluorouracil"
"84905028489","Humans"
"84905028489","Male"
"84905028489","Maximum Tolerated Dose"
"84905028489","Middle Aged"
"84905028489","Neoplasm Invasiveness"
"84905028489","Neoplasm Staging"
"84905028489","Prognosis"
"84905028489","Proportional Hazards Models"
"84905028489","Stomach Neoplasms"
"84905028489","Survival Rate"
"84905028489","Treatment Outcome"
"84891372637","Adult"
"84891372637","Aged"
"84891372637","Anemia"
"84891372637","Anorexia"
"84891372637","Antineoplastic Agents, Phytogenic"
"84891372637","Antineoplastic Combined Chemotherapy Protocols"
"84891372637","Camptothecin"
"84891372637","Drug Administration Schedule"
"84891372637","Female"
"84891372637","Fluorouracil"
"84891372637","Humans"
"84891372637","Kaplan-Meier Estimate"
"84891372637","Male"
"84891372637","Middle Aged"
"84891372637","Neutropenia"
"84891372637","Paclitaxel"
"84891372637","Platinum"
"84891372637","Prospective Studies"
"84891372637","Stomach Neoplasms"
"84891372637","Treatment Failure"
"84891372637","Treatment Outcome"
"84908139963","Adenocarcinoma"
"84908139963","Adult"
"84908139963","Aged"
"84908139963","Antibodies, Monoclonal"
"84908139963","Antineoplastic Combined Chemotherapy Protocols"
"84908139963","Confidence Intervals"
"84908139963","Disease-Free Survival"
"84908139963","Dose-Response Relationship, Drug"
"84908139963","Double-Blind Method"
"84908139963","Drug Administration Schedule"
"84908139963","Esophageal Neoplasms"
"84908139963","Esophagogastric Junction"
"84908139963","Female"
"84908139963","Humans"
"84908139963","Kaplan-Meier Estimate"
"84908139963","Male"
"84908139963","Maximum Tolerated Dose"
"84908139963","Middle Aged"
"84908139963","Paclitaxel"
"84908139963","Prognosis"
"84908139963","Proportional Hazards Models"
"84908139963","Remission Induction"
"84908139963","Stomach Neoplasms"
"84908139963","Survival Analysis"
"84908139963","Treatment Outcome"
"77957891539","Cell Line, Tumor"
"77957891539","Cell Proliferation"
"77957891539","Drug Resistance, Neoplasm"
"77957891539","Everolimus"
"77957891539","Fluorouracil"
"77957891539","G1 Phase"
"77957891539","Humans"
"77957891539","Intracellular Signaling Peptides and Proteins"
"77957891539","Protein-Serine-Threonine Kinases"
"77957891539","Sirolimus"
"77957891539","Stomach Neoplasms"
"77957891539","TOR Serine-Threonine Kinases"
"77957891539","Thymidylate Synthase"
"84891371392","Adenocarcinoma"
"84891371392","Adult"
"84891371392","Aged"
"84891371392","Aged, 80 and over"
"84891371392","Disease-Free Survival"
"84891371392","Double-Blind Method"
"84891371392","Female"
"84891371392","Humans"
"84891371392","Immunosuppressive Agents"
"84891371392","Kaplan-Meier Estimate"
"84891371392","Male"
"84891371392","Middle Aged"
"84891371392","Neoplasm Recurrence, Local"
"84891371392","Proportional Hazards Models"
"84891371392","Sirolimus"
"84891371392","Stomach Neoplasms"
"84891371392","Young Adult"
"84925222119","Adolescent"
"84925222119","Adult"
"84925222119","Aged"
"84925222119","Aged, 80 and over"
"84925222119","Antibodies, Monoclonal"
"84925222119","Antineoplastic Agents"
"84925222119","Dacarbazine"
"84925222119","Disease-Free Survival"
"84925222119","Double-Blind Method"
"84925222119","Female"
"84925222119","Humans"
"84925222119","Male"
"84925222119","Melanoma"
"84925222119","Middle Aged"
"84925222119","Programmed Cell Death 1 Receptor"
"84925222119","Proto-Oncogene Proteins B-raf"
"84925222119","Survival Rate"
"84925222119","Young Adult"
"84908354848","Adolescent"
"84908354848","Adult"
"84908354848","Aged"
"84908354848","Antibodies, Monoclonal"
"84908354848","Antineoplastic Agents"
"84908354848","Dose-Response Relationship, Drug"
"84908354848","Drug Eruptions"
"84908354848","Drug Resistance, Neoplasm"
"84908354848","Fatigue"
"84908354848","Female"
"84908354848","Humans"
"84908354848","Male"
"84908354848","Melanoma"
"84908354848","Middle Aged"
"84908354848","Programmed Cell Death 1 Receptor"
"84908354848","Pruritus"
"84908354848","Skin Neoplasms"
"84908354848","Treatment Outcome"
"84908354848","Young Adult"
"84929481480","Adult"
"84929481480","Aged"
"84929481480","Aged, 80 and over"
"84929481480","Antibodies, Monoclonal, Humanized"
"84929481480","Antigens, CD274"
"84929481480","Antineoplastic Agents"
"84929481480","Biological Markers"
"84929481480","Carcinoma, Non-Small-Cell Lung"
"84929481480","Disease-Free Survival"
"84929481480","Female"
"84929481480","Humans"
"84929481480","Infusions, Intravenous"
"84929481480","Lung Neoplasms"
"84929481480","Male"
"84929481480","Middle Aged"
"84929481480","ROC Curve"
"84929481480","Survival Analysis"
"84891915708","Adolescent"
"84891915708","Adult"
"84891915708","Aged"
"84891915708","Aged, 80 and over"
"84891915708","Antineoplastic Agents"
"84891915708","Carcinoma, Hepatocellular"
"84891915708","Disease-Free Survival"
"84891915708","Female"
"84891915708","Humans"
"84891915708","Indoles"
"84891915708","Kaplan-Meier Estimate"
"84891915708","Liver Neoplasms"
"84891915708","Male"
"84891915708","Middle Aged"
"84891915708","Niacinamide"
"84891915708","Phenylurea Compounds"
"84891915708","Proportional Hazards Models"
"84891915708","Pyrroles"
"84891915708","Young Adult"
"84885587718","Adult"
"84885587718","Aged"
"84885587718","Aged, 80 and over"
"84885587718","Alanine"
"84885587718","Carcinoma, Hepatocellular"
"84885587718","Double-Blind Method"
"84885587718","Drug Resistance, Neoplasm"
"84885587718","Female"
"84885587718","Follow-Up Studies"
"84885587718","Humans"
"84885587718","Liver Neoplasms"
"84885587718","Male"
"84885587718","Middle Aged"
"84885587718","Niacinamide"
"84885587718","Phenylurea Compounds"
"84885587718","Prognosis"
"84885587718","Protein Kinase Inhibitors"
"84885587718","Salvage Therapy"
"84885587718","Survival Rate"
"84885587718","Triazines"
"84885587718","Young Adult"
"84920993186","Adult"
"84920993186","Aged"
"84920993186","Aged, 80 and over"
"84920993186","Antineoplastic Agents"
"84920993186","Carcinoma, Hepatocellular"
"84920993186","Drug Administration Schedule"
"84920993186","Female"
"84920993186","Hand-Foot Syndrome"
"84920993186","Humans"
"84920993186","Hypertension"
"84920993186","Indazoles"
"84920993186","Kaplan-Meier Estimate"
"84920993186","Liver Neoplasms"
"84920993186","Male"
"84920993186","Middle Aged"
"84920993186","Niacinamide"
"84920993186","Odds Ratio"
"84920993186","Phenylurea Compounds"
"84920993186","Protein Kinase Inhibitors"
"84920993186","Receptor Protein-Tyrosine Kinases"
"84920993186","Risk Factors"
"84920993186","Treatment Outcome"
"84923144891","Antineoplastic Combined Chemotherapy Protocols"
"84923144891","Carcinoma, Hepatocellular"
"84923144891","Double-Blind Method"
"84923144891","Female"
"84923144891","Humans"
"84923144891","Liver Neoplasms"
"84923144891","Male"
"84923144891","Middle Aged"
"84923144891","Niacinamide"
"84923144891","Phenylurea Compounds"
"84923144891","Placebos"
"84923144891","Quinazolines"
"84885173677","Hepatocellular carcinoma"
"84885173677","Receptor kinase inhibition"
"84885173677","Regorafenib"
"84885173677","Safety"
"84885173677","Second line"
"84885173677","Tolerability"
"84922742421","Adult"
"84922742421","Aged"
"84922742421","Disease-Free Survival"
"84922742421","Female"
"84922742421","Humans"
"84922742421","Iodine Radioisotopes"
"84922742421","Kaplan-Meier Estimate"
"84922742421","Male"
"84922742421","Middle Aged"
"84922742421","Phenylurea Compounds"
"84922742421","Protein Kinase Inhibitors"
"84922742421","Quinolines"
"84922742421","Thyroid Neoplasms"
"84918777261","Adult"
"84918777261","Aged"
"84918777261","Antineoplastic Combined Chemotherapy Protocols"
"84918777261","Asian Continental Ancestry Group"
"84918777261","Biological Markers"
"84918777261","Carcinoma, Hepatocellular"
"84918777261","Diphenylamine"
"84918777261","Female"
"84918777261","Humans"
"84918777261","Liver Neoplasms"
"84918777261","Male"
"84918777261","Middle Aged"
"84918777261","Neoplasm Metastasis"
"84918777261","Neoplasm Staging"
"84918777261","Niacinamide"
"84918777261","Phenylurea Compounds"
"84918777261","Sulfonamides"
"84918777261","Treatment Outcome"
"79957985551","Autophosphorylation"
"79957985551","Catalytic residue"
"79957985551","Clinical testing"
"79957985551","Gene amplification"
"79957985551","Human malignancies"
"79957985551","In-phase"
"79957985551","In-silico"
"79957985551","Inhibitory mechanism"
"79957985551","Kinase domains"
"79957985551","Non small cell lung cancer"
"79957985551","Protein kinase"
"79957985551","Receptor tyrosine kinase"
"79957985551","Regulatory elements"
"79957985551","Structural basis"
"84890571003","Adult"
"84890571003","Aged"
"84890571003","Aged, 80 and over"
"84890571003","Anilides"
"84890571003","Calcitonin"
"84890571003","Carcinoembryonic Antigen"
"84890571003","Disease-Free Survival"
"84890571003","Double-Blind Method"
"84890571003","Female"
"84890571003","Humans"
"84890571003","Male"
"84890571003","Middle Aged"
"84890571003","Protein Kinase Inhibitors"
"84890571003","Pyridines"
"84890571003","Thyroid Neoplasms"
"62349137063","Carcinoma, Hepatocellular"
"62349137063","Humans"
"62349137063","Liver Neoplasms"
"62349137063","Neoplasm Regression, Spontaneous"
"62349137063","Placebos"
"62349137063","Randomized Controlled Trials as Topic"
"62349137063","Research Design"
"84920837701","American Cancer Society"
"84920837701","Centers for Disease Control and Prevention (U.S.)"
"84920837701","Female"
"84920837701","Humans"
"84920837701","Incidence"
"84920837701","Male"
"84920837701","Neoplasms"
"84920837701","Registries"
"84920837701","SEER Program"
"84920837701","Sex Distribution"
"84920837701","Survival Rate"
"84920837701","United States"
"84897872564","Cox proportional hazards models"
"84897872564","Distant metastasis"
"84897872564","Generalized estimating equations"
"84897872564","Kaplan-Meier method"
"84897872564","Management strategies"
"84897872564","Methods and materials"
"84897872564","Multi variate analysis"
"84897872564","Overall survival rates"
"84898978284","Early Detection of Cancer"
"84898978284","Humans"
"84898978284","Individualized Medicine"
"84898978284","Neoplasm Micrometastasis"
"84898978284","Neoplastic Cells, Circulating"
"84898978284","Urinary Bladder Neoplasms"
"84878442860","antineoplastic"
"84878442860","bladder neoplasms"
"84878442860","survival analysis"
"84878442860","transitional cell carcinoma"
"84878442860","urologic tumor"
"84919948107","Animals"
"84919948107","Antibodies, Monoclonal, Humanized"
"84919948107","Antineoplastic Agents"
"84919948107","Disease-Free Survival"
"84919948107","Humans"
"84919948107","Neoplasm Staging"
"84919948107","Neoplasms"
"84902678443","Adult"
"84902678443","Aged"
"84902678443","Aged, 80 and over"
"84902678443","Animals"
"84902678443","Antibodies, Monoclonal, Humanized"
"84902678443","Colorectal Neoplasms"
"84902678443","Drug Synergism"
"84902678443","Female"
"84902678443","Humans"
"84902678443","Male"
"84902678443","Mice"
"84902678443","Middle Aged"
"84902678443","Molecular Targeted Therapy"
"84902678443","Pregnancy Proteins"
"84902678443","Receptors, Vascular Endothelial Growth Factor"
"84902678443","Recombinant Fusion Proteins"
"84902678443","Vascular Endothelial Growth Factor A"
"84902678443","Xenograft Model Antitumor Assays"
"84921541118","Angiogenesis Inhibitors"
"84921541118","Antibodies, Monoclonal, Humanized"
"84921541118","Databases, Factual"
"84921541118","Humans"
"84921541118","Macular Degeneration"
"84921541118","Randomized Controlled Trials as Topic"
"84921541118","Receptors, Vascular Endothelial Growth Factor"
"84921541118","Recombinant Fusion Proteins"
"84921541118","Treatment Outcome"
"84921541118","Vascular Endothelial Growth Factor A"
"84921541118","Visual Acuity"
"84926219735","Antinematodal Agents"
"84926219735","Antineoplastic Combined Chemotherapy Protocols"
"84926219735","Carcinoma, Renal Cell"
"84926219735","Female"
"84926219735","Humans"
"84926219735","Lymph Node Excision"
"84926219735","Male"
"84926219735","Neoplasm Metastasis"
"84926219735","Nephrectomy"
"84926219735","Practice Guidelines as Topic"
"84926219735","Treatment Outcome"
"84926219735","Urology"
"84923130166","Aged"
"84923130166","Antineoplastic Agents"
"84923130166","Antineoplastic Combined Chemotherapy Protocols"
"84923130166","Bone Marrow Diseases"
"84923130166","Cisplatin"
"84923130166","Deoxycytidine"
"84923130166","Disease-Free Survival"
"84923130166","Female"
"84923130166","Humans"
"84923130166","Indoles"
"84923130166","Male"
"84923130166","Middle Aged"
"84923130166","Pyrroles"
"84923130166","Treatment Outcome"
"84923130166","Urologic Neoplasms"
"84910145396","Antineoplastic Agents"
"84910145396","Apoptosis"
"84910145396","Cell Line, Tumor"
"84910145396","Drug Resistance, Neoplasm"
"84910145396","Humans"
"84910145396","MAP Kinase Signaling System"
"84910145396","Niacinamide"
"84910145396","Phenylurea Compounds"
"84910145396","Protein Kinase Inhibitors"
"84910145396","Urinary Bladder"
"84910145396","Urinary Bladder Neoplasms"
"84910145396","Urothelium"
"84905175125","Adult"
"84905175125","Aged"
"84905175125","Anilides"
"84905175125","Antineoplastic Agents"
"84905175125","Carcinoma, Renal Cell"
"84905175125","Female"
"84905175125","Follow-Up Studies"
"84905175125","Humans"
"84905175125","Kidney Neoplasms"
"84905175125","Male"
"84905175125","Middle Aged"
"84905175125","Pyridines"
"84905175125","Treatment Outcome"
"84905175125","Tumor Burden"
"84904695352","Adult"
"84904695352","Aged"
"84904695352","Anilides"
"84904695352","Antineoplastic Agents"
"84904695352","Female"
"84904695352","Humans"
"84904695352","Male"
"84904695352","Middle Aged"
"84904695352","Neoplasm Metastasis"
"84904695352","Protein-Tyrosine Kinases"
"84904695352","Pyridines"
"84904695352","Sarcoma"
"84904695352","Thyroid Diseases"
"84904695352","Thyroid Gland"
"84904695352","Thyrotoxicosis"
"84904695352","Ultrasonography, Doppler"
"84904695352","Urinary Bladder Neoplasms"
"84899049029","Aged"
"84899049029","Aged, 80 and over"
"84899049029","Antineoplastic Combined Chemotherapy Protocols"
"84899049029","Carcinoma, Non-Small-Cell Lung"
"84899049029","Deoxycytidine"
"84899049029","Disease-Free Survival"
"84899049029","Double-Blind Method"
"84899049029","Female"
"84899049029","Humans"
"84899049029","Lung Neoplasms"
"84899049029","Male"
"84899049029","Piperidines"
"84899049029","Placebos"
"84899049029","Quinazolines"
"84899049029","Survival Rate"
"84904578792","Aged"
"84904578792","Anilides"
"84904578792","Antineoplastic Agents"
"84904578792","Antineoplastic Combined Chemotherapy Protocols"
"84904578792","Humans"
"84904578792","Male"
"84904578792","Nitriles"
"84904578792","Piperidines"
"84904578792","Prostate-Specific Antigen"
"84904578792","Prostatic Neoplasms, Castration-Resistant"
"84904578792","Protein Kinase Inhibitors"
"84904578792","Quinazolines"
"84904578792","Tosyl Compounds"
"84904578792","Vascular Endothelial Growth Factor A"
"84904578792","Vascular Endothelial Growth Factor Receptor-2"
"84903576582","Antineoplastic Combined Chemotherapy Protocols"
"84903576582","Carboplatin"
"84903576582","Cisplatin"
"84903576582","Doxorubicin"
"84903576582","Humans"
"84903576582","Methotrexate"
"84903576582","Urinary Bladder Neoplasms"
"84903576582","Vinblastine"
"84925384532","Area Under Curve"
"84925384532","Biomarkers, Tumor"
"84925384532","Case-Control Studies"
"84925384532","Humans"
"84925384532","Neoplasm Staging"
"84925384532","Predictive Value of Tests"
"84925384532","Proto-Oncogene Proteins c-met"
"84925384532","ROC Curve"
"84925384532","Sensitivity and Specificity"
"84925384532","Solubility"
"84925384532","Urinary Bladder Neoplasms"
"84925384532","Urothelium"
"84926168799","Animals"
"84926168799","Antineoplastic Agents"
"84926168799","Chemistry, Pharmaceutical"
"84926168799","Diffusion of Innovation"
"84926168799","Disease Models, Animal"
"84926168799","Drug Carriers"
"84926168799","Drug Delivery Systems"
"84926168799","Forecasting"
"84926168799","Humans"
"84926168799","Medical Oncology"
"84926168799","Nanomedicine"
"84926168799","Nanoparticles"
"84926168799","Neoplasms"
"84926168799","Technology, Pharmaceutical"
"84926168799","Treatment Outcome"
"84924546231","Antibodies, Monoclonal"
"84924546231","China"
"84924546231","Clinical Trials as Topic"
"84924546231","Humans"
"84924546231","Protein Engineering"
"84924546231","Publications"
"84906691195","Angiogenesis Inhibitors"
"84906691195","Antineoplastic Agents"
"84906691195","Humans"
"84906691195","Hyperthyroidism"
"84906691195","Hypothyroidism"
"84906691195","Neoplasms"
"84906691195","Protein Kinase Inhibitors"
"84906691195","Randomized Controlled Trials as Topic"
"84906691195","Receptors, Vascular Endothelial Growth Factor"
"84924207092","Adolescent"
"84924207092","Adult"
"84924207092","Aged"
"84924207092","Antibodies, Monoclonal"
"84924207092","Antineoplastic Combined Chemotherapy Protocols"
"84924207092","Carboplatin"
"84924207092","Carcinoma, Non-Small-Cell Lung"
"84924207092","Cisplatin"
"84924207092","Disease-Free Survival"
"84924207092","Female"
"84924207092","Glutamates"
"84924207092","Guanine"
"84924207092","Humans"
"84924207092","Male"
"84924207092","Middle Aged"
"84924207092","Neoplasm Metastasis"
"84924207092","Young Adult"
"84920919864","Adult"
"84920919864","Aged"
"84920919864","Aged, 80 and over"
"84920919864","Antibodies, Monoclonal"
"84920919864","Antineoplastic Combined Chemotherapy Protocols"
"84920919864","Breast Neoplasms"
"84920919864","Disease-Free Survival"
"84920919864","Double-Blind Method"
"84920919864","Drug Administration Schedule"
"84920919864","Fatigue"
"84920919864","Febrile Neutropenia"
"84920919864","Female"
"84920919864","Hand-Foot Syndrome"
"84920919864","Humans"
"84920919864","Hypertension"
"84920919864","Immunoglobulin G"
"84920919864","Kaplan-Meier Estimate"
"84920919864","Middle Aged"
"84920919864","Neoplasm Recurrence, Local"
"84920919864","Stomatitis"
"84920919864","Taxoids"
"84920919864","Treatment Outcome"
"84920948299","Animals"
"84920948299","Antineoplastic Agents"
"84920948299","Humans"
"84920948299","Neuroendocrine Tumors"
"84920948299","Prognosis"
"84920948299","Protein Kinase Inhibitors"
"84920948299","Vascular Endothelial Growth Factors"
"84912532971","Angiogenesis Inhibitors"
"84912532971","Antineoplastic Agents"
"84912532971","Cardiovascular Diseases"
"84912532971","Humans"
"84912532971","Imidazoles"
"84912532971","Incidence"
"84912532971","Indazoles"
"84912532971","Indoles"
"84912532971","Neoplasms"
"84912532971","Phenylurea Compounds"
"84912532971","Protein Kinase Inhibitors"
"84912532971","Pyridines"
"84912532971","Pyrroles"
"84912532971","Quinazolines"
"84912532971","Risk"
"84919821838","Antineoplastic Agents"
"84919821838","Clinical Trials as Topic"
"84919821838","Drug Eruptions"
"84919821838","Hand-Foot Syndrome"
"84919821838","Humans"
"84919821838","Indoles"
"84919821838","Mucositis"
"84919821838","Pyrroles"
"84923372373","Angiogenesis Inhibitors"
"84923372373","Animals"
"84923372373","Antibodies, Monoclonal"
"84923372373","Antineoplastic Agents"
"84923372373","Breast Neoplasms"
"84923372373","Drug Design"
"84923372373","Female"
"84923372373","Humans"
"84923372373","Neoplasm Metastasis"
"84923372373","Neovascularization, Pathologic"
"84923372373","Vascular Endothelial Growth Factor A"
"84881544724","Anemia"
"84881544724","Hematologic toxicities"
"84881544724","Meta-analysis"
"84881544724","Neutropenia"
"84881544724","Sunitinib"
"84881544724","Thrombocytopenia"
"84928828651","Angiogenesis Inhibitors"
"84928828651","Antibodies, Monoclonal, Humanized"
"84928828651","Antineoplastic Agents"
"84928828651","Humans"
"84928828651","Incidence"
"84928828651","Infection"
"84928828651","Neoplasms"
"84928828651","Odds Ratio"
"84928828651","Publication Bias"
"84928828651","Randomized Controlled Trials as Topic"
"84928828651","Risk"
"0035793623","Endothelial growth factors"
"0035793623","Vascular permeability"
"84903901177","Animals"
"84903901177","Humans"
"84903901177","Microvessels"
"84903901177","Neovascularization, Physiologic"
"84903901177","Regional Blood Flow"
"84903901177","Vascular Remodeling"
"84902070174","Animals"
"84902070174","Chromosomes, Human, Pair 6"
"84902070174","Comparative Genomic Hybridization"
"84902070174","Gene Amplification"
"84902070174","Genetic Loci"
"84902070174","Humans"
"84902070174","In Situ Hybridization, Fluorescence"
"84902070174","Mice"
"84902070174","Mice, Nude"
"84902070174","Microvessels"
"84902070174","Neoplasms"
"84902070174","Tissue Array Analysis"
"84902070174","Vascular Endothelial Growth Factor A"
"84902070174","Xenograft Model Antitumor Assays"
"84907591274","Angiogenesis Inhibitors"
"84907591274","Antibodies, Monoclonal, Humanized"
"84907591274","Basic Helix-Loop-Helix Transcription Factors"
"84907591274","Bayes Theorem"
"84907591274","Clinical Trials, Phase III as Topic"
"84907591274","Colorectal Neoplasms"
"84907591274","Disease-Free Survival"
"84907591274","Genetic Variation"
"84907591274","Genotype"
"84907591274","Humans"
"84907591274","Kaplan-Meier Estimate"
"84907591274","Neoplasms"
"84907591274","Randomized Controlled Trials as Topic"
"84907591274","Treatment Outcome"
"84907591274","Vascular Endothelial Growth Factor A"
"84907591274","Vascular Endothelial Growth Factor C"
"84907591274","Von Hippel-Lindau Tumor Suppressor Protein"
"84886813161","Adult"
"84886813161","Angiogenesis Inhibitors"
"84886813161","Antineoplastic Combined Chemotherapy Protocols"
"84886813161","Camptothecin"
"84886813161","Clinical Trials, Phase III as Topic"
"84886813161","Colorectal Neoplasms"
"84886813161","Drug Approval"
"84886813161","Europe"
"84886813161","Fluorouracil"
"84886813161","Humans"
"84886813161","Leucovorin"
"84886813161","Receptors, Vascular Endothelial Growth Factor"
"84886813161","Recombinant Fusion Proteins"
"84886813161","aflibercept"
"84886813161","anti-angiogenic"
"84886813161","metastatic colorectal cancer"
"84938079692","Adult"
"84938079692","Aged"
"84938079692","Angiogenesis Inhibitors"
"84938079692","Antibodies, Monoclonal"
"84938079692","Biomarkers, Tumor"
"84938079692","Disease Progression"
"84938079692","Drug Administration Schedule"
"84938079692","Female"
"84938079692","Humans"
"84938079692","Male"
"84938079692","Maximum Tolerated Dose"
"84938079692","Middle Aged"
"84938079692","Neoplasms"
"84938079692","Treatment Outcome"
"84938079692","United States"
"84938079692","Vascular Endothelial Growth Factor A"
"84938079692","Vascular Endothelial Growth Factor Receptor-1"
"84938079692","Vascular Endothelial Growth Factor Receptor-2"
"84933673498","Adult"
"84933673498","Aged"
"84933673498","Aged, 80 and over"
"84933673498","Antibodies, Monoclonal"
"84933673498","Antibodies, Monoclonal, Humanized"
"84933673498","Antineoplastic Combined Chemotherapy Protocols"
"84933673498","Bevacizumab"
"84933673498","Camptothecin"
"84933673498","Colorectal Neoplasms"
"84933673498","Disease-Free Survival"
"84933673498","Female"
"84933673498","Fluorouracil"
"84933673498","Humans"
"84933673498","Leucovorin"
"84933673498","Male"
"84933673498","Middle Aged"
"84933673498","Neoplasm Metastasis"
"84933673498","Neoplasm Staging"
"84933673498","Organoplatinum Compounds"
"84925706983","Adult"
"84925706983","Aged"
"84925706983","Antibodies, Monoclonal"
"84925706983","Antineoplastic Combined Chemotherapy Protocols"
"84925706983","Carboplatin"
"84925706983","Carcinoma, Non-Small-Cell Lung"
"84925706983","Disease-Free Survival"
"84925706983","Female"
"84925706983","Humans"
"84925706983","Lung Neoplasms"
"84925706983","Male"
"84925706983","Middle Aged"
"84925706983","Neoplasm Staging"
"84925706983","Paclitaxel"
"84884588859","Animals"
"84884588859","Esophageal Neoplasms"
"84884588859","Gastroesophageal Reflux"
"84884588859","Helicobacter Infections"
"84884588859","Helicobacter pylori"
"84884588859","Humans"
"84884588859","Incidence"
"84884588859","Neoplasm Staging"
"84884588859","Stomach Neoplasms"
"77955174673","Antineoplastic Agents"
"77955174673","Disease Progression"
"77955174673","Global Health"
"77955174673","Humans"
"77955174673","Incidence"
"77955174673","Neoplasm Staging"
"77955174673","Prognosis"
"77955174673","Stomach Neoplasms"
"77955174673","Survival Rate"
"84875521549","Angiogenesis Inhibitors"
"84875521549","Animals"
"84875521549","Antineoplastic Agents"
"84875521549","Humans"
"84875521549","Molecular Targeted Therapy"
"84875521549","Protein Kinase Inhibitors"
"84875521549","Receptor, Epidermal Growth Factor"
"84875521549","Receptor, ErbB-2"
"84875521549","Signal Transduction"
"84875521549","Stomach Neoplasms"
"84875521549","Treatment Outcome"
"84884873470","Adult"
"84884873470","Aged"
"84884873470","Antigens, CD34"
"84884873470","Breast Neoplasms"
"84884873470","Endothelium"
"84884873470","Female"
"84884873470","Humans"
"84884873470","Microscopy"
"84884873470","Middle Aged"
"84884873470","Neoplasm Invasiveness"
"84884873470","Neovascularization, Pathologic"
"84884873470","Statistics as Topic"
"84884873470","Stromal Cells"
"0030198988","Angiogenesis"
"0030198988","Cancer detection"
"0030198988","Cell adhesion"
"0030198988","Interstitial pressure"
"0030198988","Lymphatics"
"0030198988","Receptor ligand binding"
"0030198988","Solid tumors"
"0030198988","Therapeutic agents"
"0030198988","Vascular permeability"
"84916196944","Adenocarcinoma"
"84916196944","Adult"
"84916196944","Aged"
"84916196944","Antibodies, Monoclonal, Humanized"
"84916196944","Antineoplastic Combined Chemotherapy Protocols"
"84916196944","Asian Continental Ancestry Group"
"84916196944","Cisplatin"
"84916196944","Deoxycytidine"
"84916196944","Disease-Free Survival"
"84916196944","Double-Blind Method"
"84916196944","Esophageal Neoplasms"
"84916196944","Esophagogastric Junction"
"84916196944","Female"
"84916196944","Fluorouracil"
"84916196944","Humans"
"84916196944","Male"
"84916196944","Middle Aged"
"84916196944","Stomach Neoplasms"
"84916196944","Treatment Outcome"
"84919471164","Administration, Oral"
"84919471164","Aged"
"84919471164","Antineoplastic Agents"
"84919471164","Ascites"
"84919471164","Disease Progression"
"84919471164","Drug Administration Schedule"
"84919471164","Female"
"84919471164","Humans"
"84919471164","Male"
"84919471164","Middle Aged"
"84919471164","Palliative Care"
"84919471164","Paracentesis"
"84919471164","Pleural Effusion"
"84919471164","Protein Kinase Inhibitors"
"84919471164","Quality of Life"
"84919471164","Quinazolines"
"84919471164","Receptors, Vascular Endothelial Growth Factor"
"84919471164","Time Factors"
"84919471164","Treatment Outcome"
"84919471164","Vascular Endothelial Growth Factor Receptor-1"
"77955347059","Angiopoietin-1"
"77955347059","Angiopoietin-2"
"77955347059","Animals"
"77955347059","Antibodies, Neutralizing"
"77955347059","Antineoplastic Agents"
"77955347059","Drug Evaluation, Preclinical"
"77955347059","Humans"
"77955347059","Neoplasms"
"77955347059","Patents as Topic"
"77955347059","Peptides"
"77955347059","Recombinant Fusion Proteins"
"77955347059","Structure-Activity Relationship"
"84891373220","Adolescent"
"84891373220","Adult"
"84891373220","Aged"
"84891373220","Double-Blind Method"
"84891373220","Drug Resistance, Neoplasm"
"84891373220","Female"
"84891373220","Follow-Up Studies"
"84891373220","Humans"
"84891373220","International Agencies"
"84891373220","Liver Neoplasms"
"84891373220","Lung Neoplasms"
"84891373220","Male"
"84891373220","Middle Aged"
"84891373220","Neoplasm Recurrence, Local"
"84891373220","Neoplasm Staging"
"84891373220","Peritoneal Neoplasms"
"84891373220","Prognosis"
"84891373220","Pyridines"
"84891373220","Stomach Neoplasms"
"84891373220","Survival Rate"
"84891373220","Young Adult"
"84878746621","Administration, Oral"
"84878746621","Animals"
"84878746621","Antineoplastic Agents"
"84878746621","Aurora Kinase A"
"84878746621","Benzodiazepines"
"84878746621","Carcinoma, Hepatocellular"
"84878746621","Cell Cycle Checkpoints"
"84878746621","Cell Line, Tumor"
"84878746621","Cell Proliferation"
"84878746621","Dogs"
"84878746621","Female"
"84878746621","Human Umbilical Vein Endothelial Cells"
"84878746621","Humans"
"84878746621","Liver Neoplasms"
"84878746621","Male"
"84878746621","Mice"
"84878746621","Mice, Inbred BALB C"
"84878746621","Mice, Nude"
"84878746621","Mitosis"
"84878746621","Neovascularization, Pathologic"
"84878746621","Protein Kinase Inhibitors"
"84878746621","Protein Processing, Post-Translational"
"84878746621","Pyrazoles"
"84878746621","Rats"
"84878746621","Rats, Wistar"
"84878746621","Signal Transduction"
"84878746621","Stomach Neoplasms"
"84878746621","Tumor Burden"
"84878746621","Vascular Endothelial Growth Factor A"
"84878746621","Xenograft Model Antitumor Assays"
"84881104603","Hepatocellular carcinoma"
"84881104603","Platelet-derived growth factor"
"84881104603","TSU-68"
"84881104603","Transarterial chemoembolisation"
"84906242661","Adult"
"84906242661","Aged"
"84906242661","Aged, 80 and over"
"84906242661","Angiogenesis Inhibitors"
"84906242661","Antibodies, Monoclonal, Humanized"
"84906242661","Antineoplastic Agents"
"84906242661","Carcinoma, Non-Small-Cell Lung"
"84906242661","Disease-Free Survival"
"84906242661","Drug Therapy, Combination"
"84906242661","Europe"
"84906242661","Female"
"84906242661","Follow-Up Studies"
"84906242661","Humans"
"84906242661","Lung Neoplasms"
"84906242661","Male"
"84906242661","Middle Aged"
"84906242661","Prospective Studies"
"84906242661","Survival Rate"
"84906242661","Time Factors"
"84906242661","Treatment Outcome"
"84906242661","United States"
"84906242661","Vascular Endothelial Growth Factor A"
"84901595989","Antibodies, Monoclonal, Humanized"
"84901595989","Antigens, CD31"
"84901595989","Antineoplastic Combined Chemotherapy Protocols"
"84901595989","Carboplatin"
"84901595989","Carcinoma, Non-Small-Cell Lung"
"84901595989","Deoxycytidine"
"84901595989","Disease-Free Survival"
"84901595989","E-Selectin"
"84901595989","Female"
"84901595989","Fibroblast Growth Factor 2"
"84901595989","Humans"
"84901595989","Intercellular Adhesion Molecule-1"
"84901595989","Lung Neoplasms"
"84901595989","Male"
"84901595989","Neuropilins"
"84901595989","Paclitaxel"
"84901595989","Pregnancy Proteins"
"84901595989","Prospective Studies"
"84901595989","Survival Rate"
"84901595989","Tumor Markers, Biological"
"84901595989","Vascular Endothelial Growth Factor A"
"84901595989","Vascular Endothelial Growth Factor Receptor-1"
"84901595989","Vascular Endothelial Growth Factor Receptor-2"
"84911493241","Carcinoma, Non-Small-Cell Lung"
"84911493241","Combined Modality Therapy"
"84911493241","Follow-Up Studies"
"84911493241","Health Planning Guidelines"
"84911493241","Humans"
"84911493241","Lung Neoplasms"
"84911493241","Neoplasm Metastasis"
"84911493241","Neoplasm Staging"
"84911493241","Prognosis"
"84911493241","Societies, Medical"
"84888427862","Animals"
"84888427862","Antibodies, Monoclonal"
"84888427862","Clinical Trials as Topic"
"84888427862","Humans"
"84888427862","Neoplasms"
"84888427862","Vascular Endothelial Growth Factor Receptor-2"
"84899645435","Adenocarcinoma"
"84899645435","Antineoplastic Combined Chemotherapy Protocols"
"84899645435","Esophagogastric Junction"
"84899645435","Gene Amplification"
"84899645435","Gene Expression Regulation, Neoplastic"
"84899645435","Humans"
"84899645435","Molecular Targeted Therapy"
"84899645435","Protein Kinase Inhibitors"
"84899645435","Receptor, Epidermal Growth Factor"
"84899645435","Signal Transduction"
"84899645435","Stomach Neoplasms"
"84899645435","Treatment Outcome"
"84899645435","Tumor Markers, Biological"
"84883401358","Humans"
"84883401358","Prognosis"
"84883401358","Receptor, Epidermal Growth Factor"
"84883401358","Receptor, ErbB-2"
"84883401358","Stomach Neoplasms"
"84876378081","Galectin-1"
"84876378081","Gastric cancer"
"84876378081","Prognosis"
"84876378081","Vascular endothelial growth factor"
"84881542709","ARQ 197"
"84881542709","HGF receptor"
"84881542709","MET protooncogene"
"84881542709","Receptor tyrosine kinase"
"84881542709","Tivantinib"
"84881542709","Tyrosine kinase inhibitor"
"84893352389","Adult"
"84893352389","Aged"
"84893352389","Aged, 80 and over"
"84893352389","Antineoplastic Combined Chemotherapy Protocols"
"84893352389","Asian Continental Ancestry Group"
"84893352389","Carboplatin"
"84893352389","Carcinoma, Non-Small-Cell Lung"
"84893352389","Diarrhea"
"84893352389","Disease-Free Survival"
"84893352389","Double-Blind Method"
"84893352389","Female"
"84893352389","Humans"
"84893352389","Indoles"
"84893352389","Lung Neoplasms"
"84893352389","Male"
"84893352389","Middle Aged"
"84893352389","Niacinamide"
"84893352389","Paclitaxel"
"84893352389","Proportional Hazards Models"
"84893352389","Treatment Outcome"
"84893352389","Young Adult"
"84927177786","Aged"
"84927177786","Antineoplastic Combined Chemotherapy Protocols"
"84927177786","Female"
"84927177786","Hepatocyte Growth Factor"
"84927177786","Humans"
"84927177786","Male"
"84927177786","Palliative Care"
"84927177786","Proto-Oncogene Proteins c-met"
"84927177786","Retrospective Studies"
"84927177786","Stomach Neoplasms"
"84927177786","Survival Rate"
"84896586734","Adult"
"84896586734","Aged"
"84896586734","Antineoplastic Combined Chemotherapy Protocols"
"84896586734","Biomarkers, Tumor"
"84896586734","Chemotherapy, Adjuvant"
"84896586734","Female"
"84896586734","Fluorouracil"
"84896586734","Humans"
"84896586734","Leucovorin"
"84896586734","Logistic Models"
"84896586734","Male"
"84896586734","Middle Aged"
"84896586734","Multivariate Analysis"
"84896586734","Organoplatinum Compounds"
"84896586734","Receptor, ErbB-2"
"84896586734","Stomach Neoplasms"
"84896586734","Treatment Outcome"
"84896586734","Tumor Suppressor Protein p53"
"84925548115","Evidence-Based Practice"
"84925548115","Humans"
"84925548115","Meta-Analysis as Topic"
"84925548115","Periodicals as Topic"
"84925548115","Publication Bias"
"84925548115","Publishing"
"84925548115","Quality Control"
"84925548115","Review Literature as Topic"
"84925548115","Terminology as Topic"
"77954601010","Antibodies, Monoclonal"
"77954601010","Antibodies, Monoclonal, Humanized"
"77954601010","Antineoplastic Agents"
"77954601010","Carcinoma, Non-Small-Cell Lung"
"77954601010","Clinical Trials as Topic"
"77954601010","Humans"
"77954601010","Lung Neoplasms"
"77954601010","Models, Biological"
"77954601010","Receptors, Vascular Endothelial Growth Factor"
"77954601010","Signal Transduction"
"77954601010","Vascular Endothelial Growth Factor A"
"84892165925","Adenocarcinoma"
"84892165925","Adenocarcinoma, Bronchiolo-Alveolar"
"84892165925","Adult"
"84892165925","Aged"
"84892165925","Antineoplastic Combined Chemotherapy Protocols"
"84892165925","Carcinoma, Large Cell"
"84892165925","Carcinoma, Non-Small-Cell Lung"
"84892165925","Cisplatin"
"84892165925","Female"
"84892165925","Follow-Up Studies"
"84892165925","Glutamates"
"84892165925","Guanine"
"84892165925","Humans"
"84892165925","Lung Neoplasms"
"84892165925","Male"
"84892165925","Middle Aged"
"84892165925","Neoplasm Staging"
"84892165925","Prognosis"
"84892165925","Pyrimidines"
"84892165925","Sulfonamides"
"84892165925","Survival Rate"
"84906323762","Aged"
"84906323762","Antibodies, Monoclonal"
"84906323762","Anticholesteremic Agents"
"84906323762","Azetidines"
"84906323762","Double-Blind Method"
"84906323762","Female"
"84906323762","Humans"
"84906323762","Hypercholesterolemia"
"84906323762","Male"
"84906323762","Middle Aged"
"84906323762","Proprotein Convertases"
"84906323762","Serine Endopeptidases"
"84904386095","Adjuvants, Immunologic"
"84904386095","Alum Compounds"
"84904386095","Antibodies, Monoclonal"
"84904386095","Cancer Vaccines"
"84904386095","Carcinoma, Non-Small-Cell Lung"
"84904386095","Double-Blind Method"
"84904386095","Female"
"84904386095","G(M3) Ganglioside"
"84904386095","Humans"
"84904386095","Kaplan-Meier Estimate"
"84904386095","Lung Neoplasms"
"84904386095","Maintenance Chemotherapy"
"84904386095","Male"
"84904386095","Middle Aged"
"84904386095","Neoplasm Staging"
"84904386095","Placebos"
"84904386095","Proportional Hazards Models"
"84904386095","Treatment Outcome"
"84883752718","Adolescent"
"84883752718","Adult"
"84883752718","Aged"
"84883752718","Antibodies, Monoclonal"
"84883752718","Antirheumatic Agents"
"84883752718","Arthritis, Rheumatoid"
"84883752718","Double-Blind Method"
"84883752718","Drug Therapy, Combination"
"84883752718","Female"
"84883752718","Humans"
"84883752718","Immunoglobulin G"
"84883752718","Male"
"84883752718","Methotrexate"
"84883752718","Middle Aged"
"84883752718","Severity of Illness Index"
"84883752718","Treatment Outcome"
"84883752718","Young Adult"
"84883746909","Adolescent"
"84883746909","Adult"
"84883746909","Aged"
"84883746909","Antibodies, Monoclonal"
"84883746909","Antibody Formation"
"84883746909","Antirheumatic Agents"
"84883746909","Double-Blind Method"
"84883746909","Female"
"84883746909","Humans"
"84883746909","Immunoglobulin G"
"84883746909","Male"
"84883746909","Middle Aged"
"84883746909","Prospective Studies"
"84883746909","Severity of Illness Index"
"84883746909","Spondylitis, Ankylosing"
"84883746909","Treatment Outcome"
"84883746909","Young Adult"
"84903581591","Animals"
"84903581591","Antibodies, Monoclonal"
"84903581591","Drug Approval"
"84903581591","Humans"
"84903581591","Periodicals as Topic"
"84903581591","United States"
"84880128705","cancer"
"84880128705","clinical studies"
"84880128705","immunological disorders"
"84880128705","monoclonal antibodies"
"84877354216","Angiogenesis Inhibitors"
"84877354216","Animals"
"84877354216","Humans"
"84877354216","Models, Biological"
"84877354216","Neoplasms"
"84877354216","Neovascularization, Pathologic"
"84877354216","Tumor Markers, Biological"
"77953818606","Apoptosis"
"77953818606","Basic fibroblast growth factor"
"77953818606","Catalytic subunits"
"77953818606","Cell assembly"
"77953818606","Cell populations"
"77953818606","Culture media"
"77953818606","Extracellular signal-regulated kinases 1 and 2"
"77953818606","In-cell"
"77953818606","Intercellular adhesion molecule-1"
"77953818606","Necrotic cells"
"77953818606","Osteopontin"
"77953818606","Proliferating cells"
"77953818606","Protein contents"
"77953818606","Protein expressions"
"77953818606","Simulated microgravity"
"77953818606","Supernatants"
"77953818606","Tube formation"
"77953818606","Tubular structures"
"77953818606","Tumor necrosis factor receptors"
"77953818606","Vascular endothelial growth factor"
"77953818606","Von Willebrand factor"
"84916881732","Angiogenesis Inhibitors"
"84916881732","Antibodies, Monoclonal, Humanized"
"84916881732","Antineoplastic Combined Chemotherapy Protocols"
"84916881732","Breast Neoplasms"
"84916881732","Cost-Benefit Analysis"
"84916881732","Female"
"84916881732","Humans"
"84916881732","Markov Chains"
"84916881732","Paclitaxel"
"84916881732","Quality-Adjusted Life Years"
"84916881732","Receptor, ErbB-2"
"84908229537","Adult"
"84908229537","Aged"
"84908229537","Aged, 80 and over"
"84908229537","Antibodies, Monoclonal, Humanized"
"84908229537","Antineoplastic Combined Chemotherapy Protocols"
"84908229537","Breast Neoplasms"
"84908229537","China"
"84908229537","Deoxycytidine"
"84908229537","Disease-Free Survival"
"84908229537","Female"
"84908229537","Fluorouracil"
"84908229537","Humans"
"84908229537","Kaplan-Meier Estimate"
"84908229537","Middle Aged"
"84908229537","Receptor, ErbB-2"
"84908229537","Taxoids"
"84908126746","Adult"
"84908126746","Aged"
"84908126746","Antibodies, Monoclonal, Humanized"
"84908126746","Antineoplastic Combined Chemotherapy Protocols"
"84908126746","Breast Neoplasms"
"84908126746","Disease-Free Survival"
"84908126746","Dose-Response Relationship, Drug"
"84908126746","Drug Administration Schedule"
"84908126746","Follow-Up Studies"
"84908126746","Genes, erbB-2"
"84908126746","Humans"
"84908126746","Maximum Tolerated Dose"
"84908126746","Middle Aged"
"84908126746","Neoplasm Invasiveness"
"84908126746","Neoplasm Recurrence, Local"
"84908126746","Neoplasm Staging"
"84908126746","Patient Selection"
"84908126746","Remission Induction"
"84908126746","Retreatment"
"84908126746","Survival Analysis"
"84908126746","Time Factors"
"84908126746","Treatment Outcome"
"84878059586","Adult"
"84878059586","Aged"
"84878059586","Antibodies, Monoclonal, Humanized"
"84878059586","Antineoplastic Combined Chemotherapy Protocols"
"84878059586","Breast Neoplasms"
"84878059586","Deoxycytidine"
"84878059586","Disease Progression"
"84878059586","Disease-Free Survival"
"84878059586","Dose-Response Relationship, Drug"
"84878059586","Double-Blind Method"
"84878059586","Drug Administration Schedule"
"84878059586","Fatigue"
"84878059586","Female"
"84878059586","Fluorouracil"
"84878059586","Humans"
"84878059586","Kaplan-Meier Estimate"
"84878059586","Middle Aged"
"84878059586","Niacinamide"
"84878059586","Phenylurea Compounds"
"84878059586","Receptor, ErbB-2"
"84878059586","Skin Diseases"
"84878059586","Stomatitis"
"84878059586","Treatment Outcome"
"84908398750","Antibodies, Monoclonal, Humanized"
"84908398750","Antineoplastic Combined Chemotherapy Protocols"
"84908398750","Breast Neoplasms"
"84908398750","Deoxycytidine"
"84908398750","Female"
"84908398750","Fluorouracil"
"84908398750","Humans"
"84908398750","Neoplasm Recurrence, Local"
"84908398750","Taxoids"
"84888292557","Aged"
"84888292557","Carcinoma, Hepatocellular"
"84888292557","Disease Progression"
"84888292557","Female"
"84888292557","Humans"
"84888292557","Liver Neoplasms"
"84888292557","Male"
"84888292557","Middle Aged"
"84888292557","Niacinamide"
"84888292557","Phenylurea Compounds"
"84888292557","Prospective Studies"
"84888292557","Randomized Controlled Trials as Topic"
"84888292557","Survival Analysis"
"84888292557","Treatment Outcome"
"84904751197","Adult"
"84904751197","Aged"
"84904751197","Aged, 80 and over"
"84904751197","Antineoplastic Agents"
"84904751197","Carcinoma, Hepatocellular"
"84904751197","Female"
"84904751197","Humans"
"84904751197","Liver Neoplasms"
"84904751197","Male"
"84904751197","Middle Aged"
"84904751197","Niacinamide"
"84904751197","Phenylurea Compounds"
"84904751197","Prospective Studies"
"84904751197","Skin"
"84890274647","Adult"
"84890274647","Aged"
"84890274647","Aged, 80 and over"
"84890274647","Alanine"
"84890274647","Carcinoma, Hepatocellular"
"84890274647","Double-Blind Method"
"84890274647","Female"
"84890274647","Follow-Up Studies"
"84890274647","Humans"
"84890274647","Liver Neoplasms"
"84890274647","Male"
"84890274647","Middle Aged"
"84890274647","Neoplasm Staging"
"84890274647","Niacinamide"
"84890274647","Phenylurea Compounds"
"84890274647","Prognosis"
"84890274647","Protein Kinase Inhibitors"
"84890274647","Survival Rate"
"84890274647","Triazines"
"84890274647","Young Adult"
"84900384901","Diagnostic Imaging"
"84900384901","Fibrinolytic Agents"
"84900384901","Humans"
"84900384901","Magnetic Resonance Imaging"
"84900384901","Portal Vein"
"84900384901","Tomography, X-Ray Computed"
"84900384901","Ultrasonography, Doppler"
"84900384901","Venous Thrombosis"
"77950546450","Adult"
"77950546450","Aged"
"77950546450","Aged, 80 and over"
"77950546450","Antineoplastic Agents"
"77950546450","Carcinoma, Hepatocellular"
"77950546450","Disease-Free Survival"
"77950546450","Female"
"77950546450","Humans"
"77950546450","Indoles"
"77950546450","Liver Neoplasms"
"77950546450","Male"
"77950546450","Middle Aged"
"77950546450","Pyrroles"
"77950546450","Treatment Outcome"
"84891587587","Adolescent"
"84891587587","Adult"
"84891587587","Aged"
"84891587587","Antineoplastic Combined Chemotherapy Protocols"
"84891587587","Carcinoma, Hepatocellular"
"84891587587","Doxorubicin"
"84891587587","Female"
"84891587587","Fluorouracil"
"84891587587","Follow-Up Studies"
"84891587587","Humans"
"84891587587","International Agencies"
"84891587587","Leucovorin"
"84891587587","Liver Neoplasms"
"84891587587","Male"
"84891587587","Middle Aged"
"84891587587","Neoplasm Staging"
"84891587587","Organoplatinum Compounds"
"84891587587","Palliative Care"
"84891587587","Prognosis"
"84891587587","Prospective Studies"
"84891587587","Survival Rate"
"84891587587","Young Adult"
"84918563179","Antibodies, Monoclonal"
"84918563179","Antineoplastic Agents"
"84918563179","Clinical Trials as Topic"
"84918563179","Humans"
"84918563179","Stomach Neoplasms"
"84918563179","United States"
"84918563179","United States Food and Drug Administration"
"0242353266","Endothelial growth factors"
"84905444205","Adenocarcinoma"
"84905444205","Anilides"
"84905444205","Animals"
"84905444205","Antigens, CD44"
"84905444205","Antineoplastic Combined Chemotherapy Protocols"
"84905444205","Apoptosis"
"84905444205","Blotting, Western"
"84905444205","Cell Movement"
"84905444205","Cell Proliferation"
"84905444205","Cisplatin"
"84905444205","Drug Resistance, Neoplasm"
"84905444205","Female"
"84905444205","Flow Cytometry"
"84905444205","Fluorescent Antibody Technique"
"84905444205","Fluorouracil"
"84905444205","Hedgehog Proteins"
"84905444205","Humans"
"84905444205","Leucovorin"
"84905444205","Mice"
"84905444205","Mice, Inbred BALB C"
"84905444205","Mice, Nude"
"84905444205","Neoplastic Stem Cells"
"84905444205","Prognosis"
"84905444205","Pyridines"
"84905444205","RNA, Small Interfering"
"84905444205","Receptors, G-Protein-Coupled"
"84905444205","Signal Transduction"
"84905444205","Spheroids, Cellular"
"84905444205","Stomach Neoplasms"
"84905444205","Survival Rate"
"84905444205","Tumor Cells, Cultured"
"84905444205","Xenograft Model Antitumor Assays"
"84898430937","Antibodies, Monoclonal"
"84898430937","Antineoplastic Combined Chemotherapy Protocols"
"84898430937","Colorectal Neoplasms"
"84898430937","Disease-Free Survival"
"84898430937","Drug Administration Schedule"
"84898430937","Fluorouracil"
"84898430937","Humans"
"84898430937","Leucovorin"
"84898430937","Neoplasm Metastasis"
"84898430937","Organoplatinum Compounds"
"84898430937","Protein Binding"
"84898430937","Treatment Outcome"
"84898430937","Vascular Endothelial Growth Factor A"
"84898430937","Vascular Endothelial Growth Factor Receptor-2"
"84878447869","docetaxel"
"84878447869","irinotecan"
"84878447869","liposomal irinotecan"
"84878447869","oesophago-gastric cancer"
"84878447869","phase II"
"84878447869","second line"
"30744479430","Angiogenesis"
"30744479430","Immune disorders"
"84882729595","ERCC1"
"84882729595","biomarkers"
"84882729595","gastric adenocarcinoma"
"84882729595","thymidylate synthase"
"84881219215","Antineoplastic Combined Chemotherapy Protocols"
"84881219215","DNA-Binding Proteins"
"84881219215","Drug Resistance, Neoplasm"
"84881219215","Endonucleases"
"84881219215","Humans"
"84881219215","RNA, Messenger"
"84881219215","Stomach Neoplasms"
"84881219215","Thymidylate Synthase"
"84881219215","Treatment Outcome"
"84881219215","Tubulin"
"84881219215","Tumor Markers, Biological"
"77956292811","Affibody"
"77956292811","HER2 receptor"
"77956292811","Targeted drug delivery"
"77956292811","Targeted therapy"
"77956292811","Tumor marker"
"77956895978","Humans"
"77956895978","Immunohistochemistry"
"77956895978","Observer Variation"
"77956895978","Practice Guidelines as Topic"
"77956895978","Receptor, ErbB-2"
"77956895978","Reproducibility of Results"
"77956895978","Stomach Neoplasms"
"77956895978","Tissue Array Analysis"
"77956895978","Tumor Markers, Biological"
"84878439467","dietary patterns"
"84878439467","gastric cancer"
"84878439467","meta-analysis"
"84878439467","review"
"84878439467","score"
"84891941609","Adult"
"84891941609","Aged"
"84891941609","Aged, 80 and over"
"84891941609","Anti-Bacterial Agents"
"84891941609","Early Detection of Cancer"
"84891941609","Female"
"84891941609","Gastroscopy"
"84891941609","Helicobacter Infections"
"84891941609","Helicobacter pylori"
"84891941609","Humans"
"84891941609","Incidence"
"84891941609","Kaplan-Meier Estimate"
"84891941609","Male"
"84891941609","Middle Aged"
"84891941609","Neoplasm Grading"
"84891941609","Neoplasm Invasiveness"
"84891941609","Neoplasm Staging"
"84891941609","Neoplasms, Second Primary"
"84891941609","Outcome Assessment (Health Care)"
"84891941609","Republic of Korea"
"84891941609","Risk Factors"
"84891941609","Stomach Neoplasms"
"84899085244","Adult"
"84899085244","Aged"
"84899085244","Anti-Bacterial Agents"
"84899085244","Anti-Ulcer Agents"
"84899085244","Carcinoma"
"84899085244","Endoscopy"
"84899085244","Female"
"84899085244","Helicobacter Infections"
"84899085244","Humans"
"84899085244","Incidence"
"84899085244","Male"
"84899085244","Middle Aged"
"84899085244","Prospective Studies"
"84899085244","Stomach Neoplasms"
"84899085244","Treatment Outcome"
"84884286589","Gastric Cancer"
"84884286589","Gastric Carcinoma"
"84899646145","Asia"
"84899646145","Asian Continental Ancestry Group"
"84899646145","Cause of Death"
"84899646145","Helicobacter Infections"
"84899646145","Helicobacter pylori"
"84899646145","Humans"
"84899646145","Incidence"
"84899646145","Molecular Epidemiology"
"84899646145","Prevalence"
"84899646145","Prognosis"
"84899646145","Risk Factors"
"84899646145","Stomach Neoplasms"
"84899646145","Time Factors"
"84892167721","Animals"
"84892167721","Antibodies, Monoclonal, Humanized"
"84892167721","Antineoplastic Combined Chemotherapy Protocols"
"84892167721","Apoptosis"
"84892167721","Cell Line, Tumor"
"84892167721","Cell Proliferation"
"84892167721","Humans"
"84892167721","Mice"
"84892167721","Mice, Inbred BALB C"
"84892167721","Neovascularization, Pathologic"
"84892167721","Receptor, ErbB-2"
"84892167721","Receptors, Vascular Endothelial Growth Factor"
"84892167721","Recombinant Fusion Proteins"
"84892167721","Stomach Neoplasms"
"84892167721","Vascular Endothelial Growth Factor A"
"84892167721","Xenograft Model Antitumor Assays"
"77956110372","Adult"
"77956110372","Algorithms"
"77956110372","Cadherins"
"77956110372","Databases, Factual"
"77956110372","Decision Support Systems, Clinical"
"77956110372","Decision Trees"
"77956110372","Diagnosis, Differential"
"77956110372","Disease Management"
"77956110372","Endoscopy, Gastrointestinal"
"77956110372","Epithelium"
"77956110372","Female"
"77956110372","Gastric Mucosa"
"77956110372","Genetic Counseling"
"77956110372","Histocytochemistry"
"77956110372","Humans"
"77956110372","Male"
"77956110372","Neoplastic Syndromes, Hereditary"
"77956110372","Practice Guidelines as Topic"
"77956110372","Stomach Neoplasms"
"84870206736","Angiogenesis"
"84870206736","Axon guidances"
"84870206736","Cell surface receptors"
"84870206736","Cellular signaling"
"84870206736","Pathological process"
"84870206736","Pleiotropic functions"
"84870206736","Signaling pathways"
"84870206736","Vascular endothelial growth"
"84870206736","Vertebrate cells"
"84878477682","Vascular endothelial growth factor-A"
"84878477682","gastric cancer"
"84878477682","prognosis"
"84878477682","tumor growth"
"84878477682","vascular endothelial growth factor-C"
"84870875221","Adenocarcinoma"
"84870875221","Chromosomal Instability"
"84870875221","DNA Mutational Analysis"
"84870875221","Deamination"
"84870875221","Exome"
"84870875221","Genomics"
"84870875221","High-Throughput Nucleotide Sequencing"
"84870875221","Microsatellite Instability"
"84870875221","Mutation"
"84870875221","Reactive Oxygen Species"
"84870875221","Stomach Neoplasms"
"84883556549","CIs"
"84883556549","EGFR"
"84883556549","Epidermal growth factor receptor"
"84883556549","Gastric cancer"
"84883556549","HRs"
"84883556549","IHC"
"84883556549","MOOSE"
"84883556549","Observational Studies in Epidemiology group"
"84883556549","Prognosis"
"84883556549","Survival"
"84883556549","confidence intervals"
"84883556549","epidermal growth factor receptor"
"84883556549","hazard ratios"
"84883556549","immunohistochemistry"
"84894363816","Adult"
"84894363816","Aged"
"84894363816","Aged, 80 and over"
"84894363816","Antibodies, Monoclonal, Humanized"
"84894363816","Antineoplastic Agents"
"84894363816","Centromere"
"84894363816","Chromosomes, Human, Pair 17"
"84894363816","Female"
"84894363816","Gene Amplification"
"84894363816","Gene Dosage"
"84894363816","Humans"
"84894363816","Immunohistochemistry"
"84894363816","In Situ Hybridization"
"84894363816","In Situ Hybridization, Fluorescence"
"84894363816","Kaplan-Meier Estimate"
"84894363816","Male"
"84894363816","Middle Aged"
"84894363816","Prognosis"
"84894363816","Receptor, ErbB-2"
"84894363816","Stomach Neoplasms"
"84894363816","Survival Analysis"
"84894363816","Treatment Outcome"
"84881405670","HGFR"
"84881405670","MetMAb"
"84881405670","OA5D5"
"84881405670","scatter factor"
"77954410215","Adult"
"77954410215","Aged"
"77954410215","Aged, 80 and over"
"77954410215","Carcinoma, Hepatocellular"
"77954410215","Female"
"77954410215","Humans"
"77954410215","Hyperthermia, Induced"
"77954410215","Liver Neoplasms"
"77954410215","Male"
"77954410215","Microwaves"
"77954410215","Middle Aged"
"77954410215","Treatment Outcome"
"77954410215","Ultrasonography, Interventional"
"84880732021","hepatocellular carcinoma"
"84880732021","sorafenib"
"84880732021","transarterial chemoembolization"
"17044380150","Bioheat equation"
"17044380150","Cancer therapy"
"17044380150","Electropermeabilization"
"17044380150","Electroporation"
"12644292106","ADENOCARCINOMA"
"12644292106","CARCINOMA"
"12644292106","CARCINOMA, SCIRRHOUS"
"12644292106","CLASSIFICATION"
"12644292106","DIAGNOSIS, DIFFERENTIAL"
"12644292106","HISTOCYTOCHEMISTRY"
"12644292106","PATHOLOGY"
"12644292106","STOMACH NEOPLASMS"
"84890571260","PI3K"
"84890571260","PI3K inhibitor"
"84890571260","colorectal cancer"
"84890571260","gastric cancer"
"84890571260","meta-analysis"
"84890571260","mutation"
"84860157670","Antigens, CD44"
"84860157670","Female"
"84860157670","Gene Amplification"
"84860157670","Gene Dosage"
"84860157670","Humans"
"84860157670","Lymphatic Metastasis"
"84860157670","Male"
"84860157670","Middle Aged"
"84860157670","Prognosis"
"84860157670","Proto-Oncogene Proteins c-met"
"84860157670","Receptor, ErbB-4"
"84860157670","Stomach"
"84860157670","Stomach Neoplasms"
"84887108577","Biomarkers"
"84887108577","Breast cancer"
"84887108577","Molecular subtypes"
"84887108577","Proteomics"
"84887108577","Review"
"84898401323","Breast Neoplasms"
"84898401323","Drug Discovery"
"84898401323","Female"
"84898401323","Gene Expression Profiling"
"84898401323","High-Throughput Screening Assays"
"84898401323","Humans"
"84898401323","Prognosis"
"84898401323","Protein Array Analysis"
"84898401323","Proteomics"
"84898401323","Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"
"84898401323","Tumor Markers, Biological"
"77954682879","Angiogenesis Inhibitors"
"77954682879","Antibodies, Monoclonal"
"77954682879","Clinical Trials, Phase I as Topic"
"77954682879","Clinical Trials, Phase II as Topic"
"77954682879","Clinical Trials, Phase III as Topic"
"77954682879","Humans"
"77954682879","Neovascularization, Pathologic"
"77954682879","Safety"
"84884126500","Adult"
"84884126500","Aged"
"84884126500","Antineoplastic Combined Chemotherapy Protocols"
"84884126500","Breast Neoplasms"
"84884126500","Deoxycytidine"
"84884126500","Disease-Free Survival"
"84884126500","Female"
"84884126500","Fluorouracil"
"84884126500","Humans"
"84884126500","Indoles"
"84884126500","Middle Aged"
"84884126500","Neoplasm Metastasis"
"84884126500","Prospective Studies"
"84884126500","Pyrroles"
"84884126500","Young Adult"
"84883185766","5-FU"
"84883185766","5-fluorouracil"
"84883185766","BFRM"
"84883185766","Bayesian Factor Regression Modeling"
"84883185766","CHC"
"84883185766","CHC_IFS"
"84883185766","CNA"
"84883185766","CSC"
"84883185766","Cancer Classification"
"84883185766","DPD"
"84883185766","FDR"
"84883185766","GC-Class"
"84883185766","GO"
"84883185766","Gene Ontology"
"84883185766","IFS"
"84883185766","KEGG"
"84883185766","Kyoto Encyclopedia of Genes and Genomes"
"84883185766","PI3K"
"84883185766","Personalized Cancer Treatment"
"84883185766","SPEM"
"84883185766","Stomach Cancer"
"84883185766","TS"
"84883185766","cancer stem cell"
"84883185766","consensus hierarchical clustering"
"84883185766","consensus hierarchical clustering with iterative feature selection"
"84883185766","copy number alteration"
"84883185766","dihydropyrimidine dehydrogenase"
"84883185766","false discovery rate"
"84883185766","gastric cancer classifier"
"84883185766","iterative feature selection"
"84883185766","mRNA"
"84883185766","mTOR"
"84883185766","mammalian target of rapamycin"
"84883185766","messenger RNA"
"84883185766","phosphatidylinositol 3-kinase"
"84883185766","spasmolytic-polypeptide-expressing metaplasia"
"84883185766","thymidylate synthase"
"84920956735","Adult"
"84920956735","Aged"
"84920956735","Aged, 80 and over"
"84920956735","Antibodies, Monoclonal"
"84920956735","Antigens, CD274"
"84920956735","Biological Markers"
"84920956735","CTLA-4 Antigen"
"84920956735","Chemokine CX3CL1"
"84920956735","Clinical Protocols"
"84920956735","Disease-Free Survival"
"84920956735","Female"
"84920956735","Gene Expression Regulation, Neoplastic"
"84920956735","Humans"
"84920956735","Immunotherapy"
"84920956735","Lymphocytes, Tumor-Infiltrating"
"84920956735","Male"
"84920956735","Middle Aged"
"84920956735","Neoplasms"
"84920956735","Treatment Outcome"
"84920956735","Young Adult"
"84903694472","Adult"
"84903694472","Aged"
"84903694472","Aged, 80 and over"
"84903694472","Antibodies, Monoclonal"
"84903694472","Antineoplastic Combined Chemotherapy Protocols"
"84903694472","Colorectal Neoplasms"
"84903694472","Female"
"84903694472","Fluorouracil"
"84903694472","Genes, ras"
"84903694472","Humans"
"84903694472","Leucovorin"
"84903694472","Male"
"84903694472","Middle Aged"
"84903694472","Neoplasm Metastasis"
"84903694472","Organoplatinum Compounds"
"84903694472","Quality of Life"
"84925105975","Antibodies, Monoclonal"
"84925105975","Antibodies, Monoclonal, Humanized"
"84925105975","Antineoplastic Agents"
"84925105975","Chi-Square Distribution"
"84925105975","Colorectal Neoplasms"
"84925105975","DNA Mutational Analysis"
"84925105975","Disease Progression"
"84925105975","Disease-Free Survival"
"84925105975","Humans"
"84925105975","Individualized Medicine"
"84925105975","Molecular Targeted Therapy"
"84925105975","Mutation"
"84925105975","Odds Ratio"
"84925105975","Predictive Value of Tests"
"84925105975","Protein Kinase Inhibitors"
"84925105975","Proto-Oncogene Proteins B-raf"
"84925105975","Receptor, Epidermal Growth Factor"
"84925105975","Risk Factors"
"84925105975","Time Factors"
"84925105975","Treatment Outcome"
"84925105975","ras Proteins"
"84927604543","Adult"
"84927604543","Aged"
"84927604543","Aged, 80 and over"
"84927604543","Antibodies, Monoclonal"
"84927604543","Antineoplastic Agents"
"84927604543","Antineoplastic Combined Chemotherapy Protocols"
"84927604543","Colorectal Neoplasms"
"84927604543","Disease-Free Survival"
"84927604543","Female"
"84927604543","Humans"
"84927604543","Indoles"
"84927604543","Male"
"84927604543","Middle Aged"
"84927604543","Proto-Oncogene Proteins B-raf"
"84927604543","Receptor, Epidermal Growth Factor"
"84927604543","Signal Transduction"
"84927604543","Sulfonamides"
"84927604543","Treatment Outcome"
"84927604543","Young Adult"
"84923078390","Adult"
"84923078390","Aged"
"84923078390","Aged, 80 and over"
"84923078390","Antibodies, Monoclonal"
"84923078390","Antigens, CD274"
"84923078390","Female"
"84923078390","Humans"
"84923078390","Immunotherapy"
"84923078390","Male"
"84923078390","Middle Aged"
"84923078390","Treatment Outcome"
"84923078390","Urinary Bladder Neoplasms"
"84936791837","Adult"
"84936791837","Aged"
"84936791837","Antibodies, Monoclonal"
"84936791837","Antigens, CD274"
"84936791837","Antineoplastic Agents"
"84936791837","Carcinoma, Non-Small-Cell Lung"
"84936791837","Carcinoma, Squamous Cell"
"84936791837","Female"
"84936791837","Humans"
"84936791837","Immunoglobulin G"
"84936791837","Lung Neoplasms"
"84936791837","Male"
"84936791837","Middle Aged"
"84936791837","Programmed Cell Death 1 Receptor"
"84936791837","Survival Analysis"
"84936791837","Taxoids"
"84920956732","Adaptive Immunity"
"84920956732","Aged"
"84920956732","Aged, 80 and over"
"84920956732","Biomarkers"
"84920956732","CD8-Positive T-Lymphocytes"
"84920956732","Cell Proliferation"
"84920956732","Female"
"84920956732","Gene Expression Regulation, Neoplastic"
"84920956732","Humans"
"84920956732","Immunotherapy"
"84920956732","Male"
"84920956732","Melanoma"
"84920956732","Middle Aged"
"84920956732","Models, Biological"
"84920956732","Multivariate Analysis"
"84920956732","Programmed Cell Death 1 Receptor"
"84920956732","Treatment Outcome"
"84932628341","Adenocarcinoma"
"84932628341","Adult"
"84932628341","Aged"
"84932628341","Antibodies, Monoclonal, Humanized"
"84932628341","Antineoplastic Agents"
"84932628341","Colorectal Neoplasms"
"84932628341","DNA Mismatch Repair"
"84932628341","Disease-Free Survival"
"84932628341","Female"
"84932628341","Humans"
"84932628341","Kaplan-Meier Estimate"
"84932628341","Male"
"84932628341","Middle Aged"
"84932628341","Neoplasm Metastasis"
"84932628341","Programmed Cell Death 1 Receptor"
"84930276518","Aged"
"84930276518","Antineoplastic Combined Chemotherapy Protocols"
"84930276518","Asian Continental Ancestry Group"
"84930276518","Colorectal Neoplasms"
"84930276518","Disease-Free Survival"
"84930276518","Double-Blind Method"
"84930276518","Female"
"84930276518","Humans"
"84930276518","Kaplan-Meier Estimate"
"84930276518","Male"
"84930276518","Middle Aged"
"84930276518","Neoplasm Metastasis"
"84930276518","Phenylurea Compounds"
"84930276518","Pyridines"
"84930276518","Treatment Outcome"
"84938055998","Adenocarcinoma"
"84938055998","Aged"
"84938055998","Antineoplastic Agents"
"84938055998","Clinical Trials, Phase III as Topic"
"84938055998","Colorectal Neoplasms"
"84938055998","DNA Mutational Analysis"
"84938055998","DNA, Neoplasm"
"84938055998","Disease Progression"
"84938055998","Disease-Free Survival"
"84938055998","Female"
"84938055998","Genetic Predisposition to Disease"
"84938055998","Humans"
"84938055998","Individualized Medicine"
"84938055998","Kaplan-Meier Estimate"
"84938055998","Male"
"84938055998","Middle Aged"
"84938055998","Patient Selection"
"84938055998","Phenotype"
"84938055998","Phenylurea Compounds"
"84938055998","Phosphatidylinositol 3-Kinases"
"84938055998","Predictive Value of Tests"
"84938055998","Proportional Hazards Models"
"84938055998","Proto-Oncogene Proteins"
"84938055998","Proto-Oncogene Proteins B-raf"
"84938055998","Pyridines"
"84938055998","Randomized Controlled Trials as Topic"
"84938055998","Real-Time Polymerase Chain Reaction"
"84938055998","Receptor, TIE-1"
"84938055998","Retrospective Studies"
"84938055998","Time Factors"
"84938055998","Treatment Outcome"
"84938055998","Tumor Markers, Biological"
"84938055998","ras Proteins"
"84924901863","Aged"
"84924901863","Antibodies, Monoclonal"
"84924901863","Antineoplastic Agents"
"84924901863","Carcinoma, Non-Small-Cell Lung"
"84924901863","Comorbidity"
"84924901863","Disease Progression"
"84924901863","Disease-Free Survival"
"84924901863","Drug Administration Schedule"
"84924901863","Europe"
"84924901863","Female"
"84924901863","Humans"
"84924901863","Infusions, Intravenous"
"84924901863","Kaplan-Meier Estimate"
"84924901863","Lung Neoplasms"
"84924901863","Male"
"84924901863","Middle Aged"
"84924901863","Molecular Targeted Therapy"
"84924901863","Programmed Cell Death 1 Receptor"
"84924901863","Risk Factors"
"84924901863","Signal Transduction"
"84924901863","Time Factors"
"84924901863","Treatment Outcome"
"84924901863","United States"
"84893422070","Antineoplastic Combined Chemotherapy Protocols"
"84893422070","Carboplatin"
"84893422070","Carcinoma, Non-Small-Cell Lung"
"84893422070","Cisplatin"
"84893422070","Deoxycytidine"
"84893422070","Humans"
"84893422070","Lung Neoplasms"
"84893422070","Paclitaxel"
"84893422070","Randomized Controlled Trials as Topic"
"84920655625","Adult"
"84920655625","Aged"
"84920655625","Aged, 80 and over"
"84920655625","Antigens, CD274"
"84920655625","Carcinoma, Non-Small-Cell Lung"
"84920655625","Cohort Studies"
"84920655625","Female"
"84920655625","Humans"
"84920655625","Immunohistochemistry"
"84920655625","Lung Neoplasms"
"84920655625","Male"
"84920655625","Middle Aged"
"84920655625","Programmed Cell Death 1 Receptor"
"84920655625","Retrospective Studies"
"84891589158","Adult"
"84891589158","Aged"
"84891589158","Aged, 80 and over"
"84891589158","Female"
"84891589158","Gastrectomy"
"84891589158","Humans"
"84891589158","Lymphatic Metastasis"
"84891589158","Male"
"84891589158","Middle Aged"
"84891589158","Prospective Studies"
"84891589158","Sentinel Lymph Node Biopsy"
"84891589158","Stomach Neoplasms"
"84925965379","Animals"
"84925965379","Antineoplastic Agents"
"84925965379","Biomarkers, Tumor"
"84925965379","Carcinoma"
"84925965379","Cell Transformation, Neoplastic"
"84925965379","Clinical Trials as Topic"
"84925965379","Drug Evaluation, Preclinical"
"84925965379","Gene Expression Regulation, Neoplastic"
"84925965379","Humans"
"84925965379","Iodine"
"84925965379","Molecular Targeted Therapy"
"84925965379","Neoplasm Grading"
"84925965379","Prognosis"
"84925965379","Protein Kinase Inhibitors"
"84925965379","Signal Transduction"
"84925965379","Thyroid Neoplasms"
"84925965379","Treatment Outcome"
"84925965379","Vascular Endothelial Growth Factors"
"84922681694","Antineoplastic Agents"
"84922681694","Cardiotoxicity"
"84922681694","Cardiovascular Diseases"
"84922681694","Clinical Trials, Phase II as Topic"
"84922681694","Clinical Trials, Phase III as Topic"
"84922681694","Humans"
"84922681694","Neoplasms"
"84922681694","Niacinamide"
"84922681694","Phenylurea Compounds"
"84922681694","Risk Factors"
"84925283518","Angiogenesis Inhibitors"
"84925283518","Carcinoma, Renal Cell"
"84925283518","Fatigue"
"84925283518","Humans"
"84925283518","Incidence"
"84925283518","Indoles"
"84925283518","Kidney Neoplasms"
"84925283518","Niacinamide"
"84925283518","Phenylurea Compounds"
"84925283518","Pyrimidines"
"84925283518","Pyrroles"
"84925283518","Risk"
"84925283518","Sulfonamides"
"84921460787","Animals"
"84921460787","Antineoplastic Agents"
"84921460787","Drug Design"
"84921460787","Epithelial-Mesenchymal Transition"
"84921460787","Hepatocyte Growth Factor"
"84921460787","Humans"
"84921460787","Molecular Targeted Therapy"
"84921460787","Prognosis"
"84921460787","Signal Transduction"
"84921460787","Stomach Neoplasms"
"84938278146","Humans"
"84938278146","Prognosis"
"84938278146","Signal Transduction"
"84938278146","Somatomedins"
"84938278146","Stomach Neoplasms"
"84930919608","Animals"
"84930919608","Antineoplastic Agents"
"84930919608","Hedgehog Proteins"
"84930919608","Humans"
"84930919608","Prognosis"
"84930919608","Signal Transduction"
"84930919608","Stomach Neoplasms"
"77956337746","Antibodies, Monoclonal"
"77956337746","Antineoplastic Agents"
"77956337746","Clinical Trials as Topic"
"77956337746","Drug Delivery Systems"
"77956337746","Drug Design"
"77956337746","Humans"
"77956337746","Neoplasms"
"84900844248","Antibodies, Bispecific"
"84900844248","Humans"
"84900844248","Leukemia, Myeloid, Acute"
"77957995258","Adult"
"77957995258","Aged"
"77957995258","Aged, 80 and over"
"77957995258","Algorithms"
"77957995258","Antibodies, Monoclonal"
"77957995258","Antineoplastic Agents"
"77957995258","Carcinoma, Renal Cell"
"77957995258","Double-Blind Method"
"77957995258","Female"
"77957995258","Humans"
"77957995258","Immunotherapy"
"77957995258","Interleukin-6"
"77957995258","Kidney Neoplasms"
"77957995258","Male"
"77957995258","Middle Aged"
"77957995258","Neoplasm Metastasis"
"84907056599","Adult"
"84907056599","Aged"
"84907056599","Antibodies, Monoclonal"
"84907056599","Antineoplastic Agents"
"84907056599","Area Under Curve"
"84907056599","C-Reactive Protein"
"84907056599","Clinical Trials as Topic"
"84907056599","Female"
"84907056599","Giant Lymph Node Hyperplasia"
"84907056599","Half-Life"
"84907056599","Hematologic Diseases"
"84907056599","Humans"
"84907056599","Interleukin-6"
"84907056599","Male"
"84907056599","Middle Aged"
"84907056599","Placebo Effect"
"84907056599","ROC Curve"
"84907056599","Receptors, Interleukin-6"
"84907056599","Treatment Outcome"
"84879849025","Adult"
"84879849025","Aged"
"84879849025","Aged, 80 and over"
"84879849025","Antibodies, Monoclonal"
"84879849025","Antineoplastic Agents"
"84879849025","Female"
"84879849025","Giant Lymph Node Hyperplasia"
"84879849025","Hemoglobins"
"84879849025","Humans"
"84879849025","Lymphoma, B-Cell"
"84879849025","Male"
"84879849025","Middle Aged"
"84879849025","Multiple Myeloma"
"84879849025","Neoplasm Staging"
"84879849025","Treatment Outcome"
"84905005470","Adult"
"84905005470","Aged"
"84905005470","Antibodies, Monoclonal"
"84905005470","Confidence Intervals"
"84905005470","Dose-Response Relationship, Drug"
"84905005470","Double-Blind Method"
"84905005470","Drug Administration Schedule"
"84905005470","Drug-Related Side Effects and Adverse Reactions"
"84905005470","Female"
"84905005470","Follow-Up Studies"
"84905005470","Giant Lymph Node Hyperplasia"
"84905005470","Humans"
"84905005470","Infusions, Intravenous"
"84905005470","International Cooperation"
"84905005470","Male"
"84905005470","Middle Aged"
"84905005470","Reference Values"
"84905005470","Risk Assessment"
"84905005470","Severity of Illness Index"
"84905005470","Survival Rate"
"84905005470","Treatment Outcome"
"84891041748","Adenocarcinoma"
"84891041748","Antibodies, Monoclonal"
"84891041748","Clinical Trials, Phase III as Topic"
"84891041748","Disease Progression"
"84891041748","Esophageal Neoplasms"
"84891041748","Esophagogastric Junction"
"84891041748","Female"
"84891041748","Humans"
"84891041748","Male"
"84891041748","Molecular Targeted Therapy"
"84891041748","Neoplasm Staging"
"84891041748","Research Design"
"84891041748","Survival Analysis"
"84891041748","Vascular Endothelial Growth Factor Receptor-2"
"84905506991","Aged"
"84905506991","Antibodies, Monoclonal, Humanized"
"84905506991","Antineoplastic Combined Chemotherapy Protocols"
"84905506991","Chlorambucil"
"84905506991","Drug Approval"
"84905506991","Female"
"84905506991","Follow-Up Studies"
"84905506991","Humans"
"84905506991","Leukemia, Lymphocytic, Chronic, B-Cell"
"84905506991","Male"
"84905506991","Prognosis"
"84905506991","Survival Rate"
"84905506991","United States"
"84905506991","United States Food and Drug Administration"
"84897133359","Antibodies, Monoclonal, Humanized"
"84897133359","Blotting, Western"
"84897133359","Cell Line, Tumor"
"84897133359","Dimerization"
"84897133359","Epidermal Growth Factor"
"84897133359","Female"
"84897133359","Humans"
"84897133359","Immunoglobulin G"
"84897133359","Indazoles"
"84897133359","Neuregulin-1"
"84897133359","Phosphatidylinositol 3-Kinases"
"84897133359","Phosphorylation"
"84897133359","Piperazines"
"84897133359","Proto-Oncogene Proteins c-akt"
"84897133359","Pyrimidines"
"84897133359","Receptor, Epidermal Growth Factor"
"84897133359","Receptor, ErbB-3"
"84897133359","Signal Transduction"
"84897133359","Sulfonamides"
"84897133359","Triple Negative Breast Neoplasms"
"84884990167","CD5"
"84884990167","antibody combinations"
"84884990167","chronic lymphocytic leukaemia"
"84884990167","complement-dependent cytotoxicity"
"84884990167","epitope binning"
"84907494587","Animals"
"84907494587","Antibodies, Bispecific"
"84907494587","Antibodies, Monoclonal, Humanized"
"84907494587","Breast Neoplasms"
"84907494587","Cell Line, Tumor"
"84907494587","Female"
"84907494587","Humans"
"84907494587","Lymphocyte Activation"
"84907494587","Rats"
"84907494587","Rats, Sprague-Dawley"
"84907494587","Receptor, ErbB-2"
"84907494587","T-Lymphocytes"
"84919701827","Animals"
"84919701827","Antineoplastic Agents"
"84919701827","Antineoplastic Combined Chemotherapy Protocols"
"84919701827","Bicyclo Compounds, Heterocyclic"
"84919701827","Blotting, Western"
"84919701827","Cell Line, Tumor"
"84919701827","Cell Survival"
"84919701827","Cells, Cultured"
"84919701827","Child"
"84919701827","Drug Synergism"
"84919701827","Gene Expression Profiling"
"84919701827","Gene Expression Regulation, Leukemic"
"84919701827","HEK293 Cells"
"84919701827","Humans"
"84919701827","Inhibitory Concentration 50"
"84919701827","Jurkat Cells"
"84919701827","Mice, Inbred NOD"
"84919701827","Mice, SCID"
"84919701827","Oligonucleotide Array Sequence Analysis"
"84919701827","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma"
"84919701827","Proto-Oncogene Proteins c-bcl-2"
"84919701827","Reverse Transcriptase Polymerase Chain Reaction"
"84919701827","Sulfonamides"
"84919701827","Survival Analysis"
"84919701827","Tumor Cells, Cultured"
"84919701827","Xenograft Model Antitumor Assays"
"84925604287","Aminopyridines"
"84925604287","Animals"
"84925604287","Apoptosis"
"84925604287","Benzimidazoles"
"84925604287","Cell Line, Tumor"
"84925604287","Cell Proliferation"
"84925604287","Cyclin D1"
"84925604287","Cyclin-Dependent Kinase 4"
"84925604287","Cyclin-Dependent Kinase 6"
"84925604287","Drug Resistance, Neoplasm"
"84925604287","Female"
"84925604287","Humans"
"84925604287","Indoles"
"84925604287","MAP Kinase Signaling System"
"84925604287","Mice"
"84925604287","Mice, Nude"
"84925604287","Protein Kinase Inhibitors"
"84925604287","Signal Transduction"
"84925604287","Sulfonamides"
"84925604287","Transfection"
"84925604287","Up-Regulation"
"84925604287","Xenograft Model Antitumor Assays"
"84930696140","Aminopyridines"
"84930696140","Animals"
"84930696140","Antineoplastic Agents"
"84930696140","Benzimidazoles"
"84930696140","Cell Line, Tumor"
"84930696140","Cyclin-Dependent Kinase 4"
"84930696140","Cyclin-Dependent Kinase 6"
"84930696140","Deoxycytidine"
"84930696140","Drug Therapy, Combination"
"84930696140","Female"
"84930696140","G1 Phase Cell Cycle Checkpoints"
"84930696140","Humans"
"84930696140","Mice"
"84930696140","Neoplasms"
"84930696140","Phosphorylation"
"84930696140","Protein Kinase Inhibitors"
"84930696140","Retinoblastoma Protein"
"84930696140","Tumor Burden"
"84930696140","Xenograft Model Antitumor Assays"
"84863688504","Cancer drug"
"84863688504","Expression profile"
"84863688504","Normal tissue"
"84863688504","Target cells"
"84863688504","Tumor cells"
"84863688504","US Food and Drug Administration"
"84883589236","glycoengineered monoclonal antibody"
"84883589236","human CD20"
"84883589236","primary intracerebral B cell lymphoma (PCL)"
"84883589236","primary intraocular B cell lymphoma (PIOL)"
"84883589236","primary vitreoretinal lymphoma (PVRL)"
"84883589236","ublituximab"
"84917690659","Animals"
"84917690659","Antibodies, Monoclonal"
"84917690659","Antibodies, Monoclonal, Humanized"
"84917690659","Antibodies, Neutralizing"
"84917690659","Antineoplastic Agents"
"84917690659","Cell Line, Tumor"
"84917690659","Cell Proliferation"
"84917690659","Disease Models, Animal"
"84917690659","Down-Regulation"
"84917690659","Enzyme Activation"
"84917690659","Female"
"84917690659","Hepatocyte Growth Factor"
"84917690659","Humans"
"84917690659","Macaca fascicularis"
"84917690659","Male"
"84917690659","Mice"
"84917690659","Neoplasms"
"84917690659","Phosphorylation"
"84917690659","Protein Transport"
"84917690659","Proteolysis"
"84917690659","Proto-Oncogene Proteins c-met"
"84917690659","Tumor Burden"
"84917690659","Xenograft Model Antitumor Assays"
"77957341503","Antibodies, Monoclonal"
"77957341503","Antineoplastic Agents"
"77957341503","Child"
"77957341503","Child, Preschool"
"77957341503","Combined Modality Therapy"
"77957341503","Drug Therapy, Combination"
"77957341503","Gangliosides"
"77957341503","Granulocyte-Macrophage Colony-Stimulating Factor"
"77957341503","Humans"
"77957341503","Immunotherapy"
"77957341503","Infant"
"77957341503","Intention to Treat Analysis"
"77957341503","Interleukin-2"
"77957341503","Isotretinoin"
"77957341503","Neuroblastoma"
"77957341503","Stem Cell Transplantation"
"77957341503","Survival Analysis"
"65649108094","Biophysical techniques"
"65649108094","Blocking mechanisms"
"65649108094","Blocking properties"
"65649108094","Clinical efficacy"
"65649108094","Clinical study"
"65649108094","Conformational change"
"65649108094","Human patients"
"65649108094","In-vitro"
"65649108094","In-vivo"
"65649108094","Inhibitory mechanism"
"65649108094","Insulin-like growth factor receptors"
"65649108094","Ligand binding"
"65649108094","Ligand concentration"
"65649108094","Mechanism of action"
"65649108094","Outer surface"
"65649108094","Preliminary data"
"65649108094","Signaling cascades"
"65649108094","Therapeutic antibodies"
"65649108094","Tumor cells"
"84902662529","Animals"
"84902662529","Antineoplastic Agents"
"84902662529","Apoptosis"
"84902662529","Binding Sites"
"84902662529","Carcinoma, Hepatocellular"
"84902662529","Cell Line, Tumor"
"84902662529","Cell Proliferation"
"84902662529","Humans"
"84902662529","Indoles"
"84902662529","Liver Neoplasms"
"84902662529","Male"
"84902662529","Mice"
"84902662529","Mice, Nude"
"84902662529","Models, Molecular"
"84902662529","Mutant Proteins"
"84902662529","Protein Conformation"
"84902662529","Protein Kinase Inhibitors"
"84902662529","Protein Tyrosine Phosphatase, Non-Receptor Type 6"
"84902662529","Receptor Protein-Tyrosine Kinases"
"84902662529","STAT3 Transcription Factor"
"84902662529","Signal Transduction"
"84902662529","Xenograft Model Antitumor Assays"
"84901611471","Antineoplastic Agents"
"84901611471","Apoptosis"
"84901611471","Apoptosis Regulatory Proteins"
"84901611471","Blood Platelets"
"84901611471","Carcinoma, Hepatocellular"
"84901611471","Cell Movement"
"84901611471","Cell Proliferation"
"84901611471","Enzyme Activation"
"84901611471","Epidermal Growth Factor"
"84901611471","Extracellular Signal-Regulated MAP Kinases"
"84901611471","Hep G2 Cells"
"84901611471","Humans"
"84901611471","Insulin-Like Growth Factor I"
"84901611471","Liver Neoplasms"
"84901611471","Neoplasm Invasiveness"
"84901611471","Niacinamide"
"84901611471","Phenylurea Compounds"
"84901611471","Phosphorylation"
"84901611471","Protein Kinase Inhibitors"
"84901611471","Pyridines"
"84901611471","Signal Transduction"
"84901611471","Time Factors"
"84901747256","Anilides"
"84901747256","Animals"
"84901747256","Antineoplastic Agents"
"84901747256","Blotting, Western"
"84901747256","Carcinoma, Hepatocellular"
"84901747256","Cell Proliferation"
"84901747256","Drug Resistance, Neoplasm"
"84901747256","Female"
"84901747256","Humans"
"84901747256","Immunohistochemistry"
"84901747256","Liver Neoplasms"
"84901747256","Mice"
"84901747256","Mice, Inbred BALB C"
"84901747256","Neoplasm Invasiveness"
"84901747256","Niacinamide"
"84901747256","Phenylurea Compounds"
"84901747256","Proto-Oncogene Proteins c-met"
"84901747256","Pyridines"
"84901747256","Vascular Endothelial Growth Factor Receptor-2"
"84901747256","Xenograft Model Antitumor Assays"
"84921032058","Antibodies, Monoclonal, Humanized"
"84921032058","Antigens, CD274"
"84921032058","Antineoplastic Agents"
"84921032058","Humans"
"84921032058","Melanoma"
"84921032058","Programmed Cell Death 1 Ligand 2 Protein"
"84921032058","Programmed Cell Death 1 Receptor"
"84926356283","Antineoplastic Agents"
"84926356283","Colorectal Neoplasms"
"84926356283","Drug Resistance, Neoplasm"
"84926356283","Humans"
"84926356283","MAP Kinase Signaling System"
"84926356283","Receptor, Epidermal Growth Factor"
"84926356283","Translational Medical Research"
"84926356283","Treatment Outcome"
"84926356283","ras Proteins"
"84922480584","Adolescent"
"84922480584","Adult"
"84922480584","Aged"
"84922480584","Aged, 80 and over"
"84922480584","Colorectal Neoplasms"
"84922480584","Female"
"84922480584","Follow-Up Studies"
"84922480584","Humans"
"84922480584","Immunoenzyme Techniques"
"84922480584","Lymphatic Metastasis"
"84922480584","Male"
"84922480584","Middle Aged"
"84922480584","Neoplasm Staging"
"84922480584","Prognosis"
"84922480584","Receptor, ErbB-2"
"84922480584","Retrospective Studies"
"84922480584","Survival Rate"
"84922480584","Tissue Array Analysis"
"84922480584","Tumor Markers, Biological"
"84922480584","Young Adult"
"84905850596","Antineoplastic Agents"
"84905850596","Clinical Trials as Topic"
"84905850596","Diffusion of Innovation"
"84905850596","Drug Resistance, Neoplasm"
"84905850596","Genetic Predisposition to Disease"
"84905850596","Humans"
"84905850596","Individualized Medicine"
"84905850596","Medical Oncology"
"84905850596","Molecular Diagnostic Techniques"
"84905850596","Molecular Targeted Therapy"
"84905850596","National Cancer Institute (U.S.)"
"84905850596","Neoplasm Metastasis"
"84905850596","Neoplasms"
"84905850596","Patient Selection"
"84905850596","Phenotype"
"84905850596","Predictive Value of Tests"
"84905850596","Registries"
"84905850596","Research Design"
"84905850596","Treatment Outcome"
"84905850596","Tumor Markers, Biological"
"84905850596","United States"
"84891370054","Hepatocellular carcinoma"
"84891370054","c-MET"
"84891370054","copy number variation"
"84891370054","immunohistochemistry"
"84891370054","prognosis"
"84904445789","Angiogenic Proteins"
"84904445789","Biomarkers, Pharmacological"
"84904445789","Blood Proteins"
"84904445789","Disease Progression"
"84904445789","Drug Administration Schedule"
"84904445789","Gene Expression Regulation, Neoplastic"
"84904445789","Humans"
"84904445789","Neoplasms"
"84904445789","Phenylurea Compounds"
"84904445789","Protein Kinase Inhibitors"
"84904445789","Quinolines"
"84904445789","Treatment Outcome"
"84922252607","Adult"
"84922252607","Aged"
"84922252607","Aged, 80 and over"
"84922252607","Alanine"
"84922252607","Carcinoma, Hepatocellular"
"84922252607","Chemoembolization, Therapeutic"
"84922252607","Chemotherapy, Adjuvant"
"84922252607","Double-Blind Method"
"84922252607","Female"
"84922252607","Humans"
"84922252607","Liver Neoplasms"
"84922252607","Male"
"84922252607","Middle Aged"
"84922252607","Receptors, Fibroblast Growth Factor"
"84922252607","Treatment Failure"
"84922252607","Triazines"
"84922252607","Vascular Endothelial Growth Factor A"
"84922252607","Young Adult"
"84904054856","Animals"
"84904054856","Antineoplastic Agents"
"84904054856","Carcinoma, Hepatocellular"
"84904054856","Cell Line, Tumor"
"84904054856","Cell Proliferation"
"84904054856","Female"
"84904054856","Hepatocytes"
"84904054856","Humans"
"84904054856","Liver Neoplasms"
"84904054856","Macrophages"
"84904054856","Male"
"84904054856","Mice, Knockout"
"84904054856","Niacinamide"
"84904054856","P-Glycoproteins"
"84904054856","Phenylurea Compounds"
"84904054856","Protein Kinase Inhibitors"
"84904054856","Tumor Burden"
"84904054856","Vascular Endothelial Growth Factor A"
"84898989382","Antineoplastic Combined Chemotherapy Protocols"
"84898989382","Carcinoma, Hepatocellular"
"84898989382","Clinical Trials, Phase III as Topic"
"84898989382","Humans"
"84898989382","Liver Neoplasms"
"84898989382","Molecular Targeted Therapy"
"84898989382","Randomized Controlled Trials as Topic"
"84898989382","Research Design"
"84898989382","Treatment Failure"
"84897542316","Adult"
"84897542316","Aged"
"84897542316","Aged, 80 and over"
"84897542316","Disease-Free Survival"
"84897542316","Extracellular Signal-Regulated MAP Kinases"
"84897542316","Female"
"84897542316","Gastrectomy"
"84897542316","Humans"
"84897542316","Hypoxia-Inducible Factor 1, alpha Subunit"
"84897542316","Immunohistochemistry"
"84897542316","Kaplan-Meier Estimate"
"84897542316","Male"
"84897542316","Middle Aged"
"84897542316","Multivariate Analysis"
"84897542316","Phosphorylation"
"84897542316","Receptor, ErbB-2"
"84897542316","Stomach Neoplasms"
"84897542316","Transforming Growth Factor beta"
"84897542316","Vascular Endothelial Growth Factor A"
"84897542316","Young Adult"
